Document:

EX-4.5

 Exhibit 4.5 

SHEARMAN & STERLING 
 EXECUTION
VERSION 
 Dated 8 October 2021 

BABYLON HOLDINGS LIMITED 

as Issuer 
 - and –

 THE ENTITIES LISTED HEREIN AS NOTE SUBSCRIBERS 

as Note Subscribers 
  

 
 Up to
US$200,000,000 
 NOTE SUBSCRIPTION AGREEMENT 
  

 
 WE OPERATE IN THE UK AND ITALY
AS SHEARMAN & STERLING (LONDON) LLP, A LIMITED LIABILITY PARTNERSHIP ORGANISED IN THE UNITED STATES UNDER THE LAWS OF THE STATE OF DELAWARE, WHICH LAWS LIMIT THE PERSONAL LIABILITY OF PARTNERS. SHEARMAN & STERLING (LONDON) LLP IS
AUTHORISED AND REGULATED BY THE SOLICITORS REGULATION AUTHORITY (FIRM SRA NUMBER 211340). A LIST OF ALL PARTNERS’ NAMES, WHICH INCLUDES SOLICITORS AND REGISTERED FOREIGN LAWYERS, IS OPEN FOR INSPECTION AT THE ABOVE ADDRESS. EACH PARTNER OF
SHEARMAN & STERLING (LONDON) LLP IS ALSO A PARTNER OF SHEARMAN & STERLING LLP WHICH HAS OFFICES IN THE OTHER CITIES NOTED ABOVE. 

 TABLE OF CONTENTS 

 

							
	Clause	  	Headings	  	Page	 
			
	 1.
	  	 DEFINITIONS AND INTERPRETATION
	  	 	1	 
			
	 2.
	  	 ISSUE OF THE NOTES
	  	 	6	 
			
	 3.
	  	 CONDITIONS
	  	 	7	 
			
	 4.
	  	 CLOSING
	  	 	9	 
			
	 5.
	  	 REPRESENTATIONS
	  	 	10	 
			
	 6.
	  	 CONFIDENTIALITY
	  	 	10	 
			
	 7.
	  	 OTHER PROVISIONS
	  	 	12	 
		
	 SCHEDULE 1 THE NOTE SUBSCRIBERS
	  	 	19	 
		
	 SCHEDULE 2 REPRESENTATIONS
	  	 	20	 
		
	 SCHEDULE 3 SHARE CAPITAL OF THE ISSUER
	  	 	26	 

  

 THIS NOTE SUBSCRIPTION AGREEMENT (the “Agreement”) is made on 8 October
2021 
 BETWEEN: 
  

	(1)	 BABYLON HOLDINGS LIMITED, a company incorporated in Jersey under registration number 115471 whose
registered office is 31 Esplanade, St. Helier, Jersey JE2 3QA (the “Issuer”); and 

  

	(2)	 THE ENTITIES listed in Schedule 1 (The Note Subscribers) (the “Note
Subscribers” and each a “Note Subscriber”), 

 (each a “Party” and together the
“Parties”).  
 WHEREAS: 
  

	(A)	 On the Closing Date (as defined below), the Issuer plans to issue to the Note Subscribers up to
US$200,000,000 Notes due 2026 (the “ Notes”).  

  

	(B)	 The Notes shall be constituted by way of a deed poll in the Agreed Form to be entered into by the Issuer (the
“Deed Poll”) on the Closing Date and shall have the terms and conditions (the “Conditions”) set out in Schedule 1 to the Deed Poll. 

 

	(C)	 The Notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the
“Securities Act”), and may not be offered or sold directly or indirectly within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

  

	(D)	 The offering of Notes is being made by the Issuer in a private placement transaction in a manner not requiring
registration under the Securities Act. 

  

	(E)	 The Notes will be represented by certificates (each, a “Certificate” and together, the
“Certificates”), duly executed and registered in the Register in the name of each Note Subscriber in respect of such Note Subscriber’s holding of the Notes. 

IT IS AGREED as follows: 
  

	1.	 DEFINITIONS AND INTERPRETATION  

In this Agreement, unless the context otherwise requires, the provisions in this Clause 1 (Definitions and Interpretation) apply:

  

	1.1	 Definitions  

“Affiliate” means, in relation to any person, a Subsidiary of that person or a holding company of that person or any other
Subsidiary of that holding company; 
 “Agreed Form” means, in relation to any document, the form of that document
which has been identified as agreed by or on behalf of each of the Parties on or before the date of this Agreement, with such changes as each Party may expressly agree in writing before the Closing Date; 

“Anti-Corruption Laws” means all laws, rules, and regulations of any jurisdiction applicable to the Issuer or its
Subsidiaries from time to time concerning or relating to bribery or corruption; 
 “Anti-Money Laundering Laws” means
all applicable financial recordkeeping and reporting requirements and laws or regulations related to money laundering or terrorist financing, including the anti-money laundering statutes and the rules and regulations thereunder and any related or
similar laws, rules, regulations or guidelines in any jurisdiction to which the Issuer or Subsidiary is subject or in which the proceeds of the Notes will be used; 

  
 1 

 “Applicable Laws” means all laws, regulations, directives, statutes,
subordinate legislation, common law and civil code of any jurisdiction, all judgments, orders, notices, instructions, decisions and awards of any court or competent authority or tribunal and all codes of practice having force of law, statutory
guidance and policy notes; 
 “Associated Company” means in relation to a person, (a) any of its Affiliates, or
any fund, partnership, special purpose vehicle or similar vehicle (the “Entity”) in respect of which the person or any of its Affiliates is (i) a limited partner or the general partner; or (ii) an investment
manager; or (iii) directly or indirectly Controls the Entity or (b) any investor of an Entity of such person and for the purposes of this definition, “Control” means in relation to any person, where a person has
direct or indirect control over more than 50% of the voting share capital of the relevant person and “Controls” shall have a corresponding meaning; 

“Authorisation” means an authorisation, consent, approval, resolution, licence, exemption, filing, notarisation or
registration; 
 “Business Combination” has the meaning given to it in the proxy statement for special meeting of
stockholders of Alkuri Global Acquisition Corp. dated 2 July 2021; 
 “Business Day” means, a day (other than
Saturday or Sunday) on which commercial banks and foreign exchange markets are open for business in Dublin, London, New York and Jersey; 

“Certificate” has the meaning given to it in Recital (E); 

“Closing” means the completion of the issue and subscription of the Notes pursuant to Clause 4 (Closing) of this
Agreement; 
 “Closing Date” means the date that is ten (10) Business Days after the occurrence of the
Effective Time of the Business Combination and unless agreed otherwise between the Issuer and the Note Subscribers, shall not be later than 31 December 2021; 

“Conditions” has the meaning given to it in Recital (B); 

“Confidential Information” has the meaning given to it in Clause 6.1 (Confidential Information);  

“Deed Poll” has the meaning given to it in Recital (B), in the Agreed Form as at the date of this Agreement; 

“Default” means any event or circumstance which (with the expiry of a grace period, the giving of notice, the making of any
determination or any combination of the foregoing) would constitute (after the issue of the Notes) an Event of Default; 

“Effective Time” has the meaning given to it in the proxy statement for special meeting of stockholders of Alkuri
Global Acquisition Corp. dated 30 September 2021; 
 “Event of Default” has the meaning given to such term in
the Conditions; 
 “Existing Shareholders” means the shareholders listed in the certified share register excerpt of
the Issuer dated as of the date of this Agreement; 
 “Financial Indebtedness” has the meaning given to it in the
Conditions; 
 “FSMA” means the Financial Services and Markets Act 2000; 

  
 2 

 “Group” has the meaning given to it in the definition of Material
Adverse Effect; 
 “Instrument” means the Deed Poll together with the Conditions; 

“Intellectual Property” means: 
  

	 	(a)	 any patents, trade marks, service marks, designs, business names, copyrights, database rights, design rights,
domain names, moral rights, inventions, confidential information, knowhow and other intellectual property rights and interests (which may on or after the date of this Agreement subsist), whether registered or unregistered; and 

 

	 	(b)	 the benefit of all applications and rights to use such assets of the Issuer (which may on or after the date of
this Agreement subsist); 

 “Issue Price” means 95.50 per cent. of the Principal Amount; 

“Jersey Registrar” has the meaning given to it in paragraph 1.19(d) of Schedule 2; 

“Joint Venture” has the meaning given to it in the Conditions; 

“Legal Reservations” means: 
  

	 	(a)	 the principle that equitable remedies may be granted or refused at the discretion of a court and the limitation
of enforcement by laws relating to insolvency, reorganisation and other laws generally affecting the rights of creditors; 

  

	 	(b)	 the time barring of claims under the Limitation Acts, the possibility that an undertaking to assume liability
for or indemnify a person against non-payment of UK stamp duty may be void and defences of set-off or counterclaim; 

 

	 	(c)	 similar principles, rights and defences under the laws of any other relevant jurisdiction; and

  

	 	(d)	 any general principles of law which are set out as qualifications to matters of law in any legal opinions
delivered pursuant to Clause 3.1 (Conditions Precedent); 

 “Limitation Acts” means
the Limitation Act 1980 and the Foreign Limitation Periods Act 1984; 
 “Material Adverse Effect” has the meaning
given to it in the Conditions; 
 “Notes” has the meaning given to it in Recital (A); 

“Party” means a party to this Agreement and “Parties” shall be construed accordingly; 

“PIPE Investors” means the third party investors participating in a private placement of the Class A ordinary
shares of the Issuer, closing of which will occur at the Effective Time of the Business Combination; 
 “Principal
Amount” means the aggregate principal amount of the Notes denominated in dollars which shall be determined by the Issuer and confirmed in writing to the Note Subscribers on or before the occurrence of the Effective Time of the Business
Combination, and which shall not be less than US$100,000,000 and no more than US$200,000,000; 
 “Proceedings” has the
meaning given to it in Clause 7.2.1; 
 “Prospectus Regulation” means Regulation (EU) 2017/1129; 

  
 3 

 “Quasi-Security” has the meaning given to it in the Conditions; 

“Register” has the meaning given to it in the Conditions; 

“Representative” means any delegate, agent, manager, administrator, nominee, attorney, trustee or custodian; 

“Right” means any right, power or remedy in connection with this Agreement; 

“Sanctioned Country” means, at any time, any country or other territory that is the subject of comprehensive
country-wide Sanctions, which at the date of this Agreement, are Crimea (as defined and construed in the applicable Sanctions), Cuba, Iran, North Korea, South Sudan and Syria; 

“Sanctioned Person” means, at any time, any individual or entity that is: 

 

	 	(a)	 listed on, owned 50% or more, or otherwise controlled (directly or indirectly) by a person listed on a
Sanctions List; 

  

	 	(b)	 a government of a Sanctioned Country; 

 

	 	(c)	 an agency or entity directly or indirectly owned 50% or more or controlled by, a government of a Sanctioned
Country; or 

  

	 	(d)	 located, incorporated, organised or ordinarily resident in a Sanctioned Country. 

“Sanctions” means any trade, financial or economic sanctions or trade embargoes imposed, enacted, administered or enforced by
the United States of America (including, without limitation, the Office of Foreign Assets Control of the US Department of the Treasury), the United Nations Security Council, the United Kingdom, the European Union, Jersey, and/or the governments and
official institutions or agencies of any of the aforementioned; 
 “Sanctions List” means any of the lists of
specifically designated nationals or similarly sanctioned individuals or entities (or equivalent) issued by the authorities listed in the definition of “Sanctions”; 

“Securities Act” has the meaning given to it in Recital (C); 

“Security” has the meaning given to it in the Conditions; 

“Shares” means shares in the capital of the Issuer; 

A company is a “Subsidiary” of another company (its “holding company”) if that other company, directly
or indirectly, through one or more subsidiaries: 
  

	 	(a)	 holds a majority of the voting rights in it; 

 

	 	(b)	 is a member or shareholder of it and has the right to appoint or remove a majority of its board of directors or
equivalent managing body; 

  

	 	(c)	 is a member or shareholder of it and controls alone, or pursuant to an agreement with other shareholders or
members, a majority of the voting rights in it; or 

  

	 	(d)	 has the right to exercise a dominant influence over it, for example by having the right to give directions with
respect to its operating and financial policies, with which directions its directors are obliged to comply; 

  
 4 

 “Tax” means any tax, levy, impost, duty or other charge or withholding of a
similar nature (including any penalty or interest payable in connection with any failure to pay or any delay in paying any of the same); 

“Transaction Documents” means: 
  

	 	(a)	 this Agreement; 

  

	 	(b)	 the Instrument; and 

  

	 	(c)	 the Warrant Instrument; 

“UK” means the United Kingdom; 

“UK Prospectus Regulation” means Regulation (EU) 2017/1129 as it forms part of domestic law in the UK by virtue of the
European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020); 
 “Warrantholder
Register” means a register of persons in whose names a Warrant is registered from time to time; 
 “Warrants” mean
the warrants to be issued to the Note Subscribers and constituted pursuant to the Warrant Instrument executed by the Issuer on or about the Closing Date; and 

“Warrant Instrument” means the warrant instrument in the Agreed Form to be entered into by the Issuer in favour of the
Note Subscribers on the Closing Date. 
  

	1.2	 Singular, plural, gender  

References to one gender include all genders and references to the singular include the plural and vice versa. 

 

	1.3	 References to persons and companies  

References to: 
  

	 	1.3.1.	 a person include any company, corporation, firm, joint venture, partnership, fund or unincorporated association
(whether or not having separate legal personality); and 

  

	 	1.3.2.	 a company include any company, corporation or any body corporate, wherever incorporated. 

 

	1.4	 Modification etc. of statutes  

References to a statute or statutory provision include: 
  

	 	1.4.1.	 that statute or provision as from time to time modified, re-enacted or
consolidated whether before or after the date of this Agreement; 

  

	 	1.4.2.	 any past statute or statutory provision (as from time to time modified,
re-enacted or consolidated) which that statute or provision has directly or indirectly replaced; and 

  

	 	1.4.3.	 any subordinate legislation made from time to time under that statute or statutory provision.

  

	1.5	 Headings  

Headings shall be ignored in interpreting this Agreement. 

  
 5 

	1.6	 Schedules etc.  

References to this Agreement shall include any Recitals and Schedules to it and references to Clauses and Schedules are to Clauses of, and
Schedules to, this Agreement. References to paragraphs are to paragraphs of the Schedules. 
  

	1.7	 Legal terms  

References to any English legal term shall, in respect of any jurisdiction other than England, be construed as references to the term or
concept which most nearly corresponds to it in that jurisdiction. 
  

	1.8	 Currency Symbols and Definitions  

“$”, “US$” and “dollar” denote the single currency of the United States of America. 

 

	2.	 ISSUE OF THE NOTES  

 

	2.1	 Undertaking to issue the Notes  

Subject to, and in accordance with, the provisions of this Agreement, the Issuer undertakes to each Note Subscriber that: 

 

	 	2.1.1.	 the Issuer will issue the Notes to each Note Subscriber on the Closing Date in the principal amount equal to
the proportion of the Principal Amount specified opposite each Note Subscriber’s name in Schedule 1 (The Note Subscribers) (the “Subscription Amount”), in accordance with this Agreement; and

  

	 	2.1.2.	 the Issuer will, on or before the Closing Date, execute the Deed Poll. 

 

	2.2	 Undertaking to subscribe  

Subject to, and in accordance with, the provisions of this Agreement, each Note Subscriber undertakes to the Issuer to subscribe for its
proportion of the principal amount of the Notes at the Issue Price on the Closing Date and to procure payment of the Issue Price in respect of its proportion of the principal amount of the Notes in accordance with Clause 4.2.3 (Payment of Issue
Price).  
  

	2.3	 Costs and Expenses  

The Issuer shall, subject to the Closing Date occurring, pay the Note Subscribers the amount of all costs and expenses (including the fees of
Shearman & Sterling (London) LLP, Ogier (Jersey) LLP and Duff & Phelps) up to a maximum aggregate amount of US$500,000 inclusive of VAT, which are properly incurred and documented by the Note Subscribers in connection with the
negotiation, preparation and execution of this Agreement and any other documents referred to in this Agreement (including any Transaction Document) by the date that is no later than 30 calendar days following the Closing Date. 

 

	2.4	 Stamp Duties  

The Issuer shall pay any and all stamp, registration and other similar taxes and duties (including any interest and penalties thereon or in
connection therewith) which are payable upon or in connection with the authorisation, creation, issuance and delivery of the Notes and the execution, delivery and performance of the Transaction Documents and the Issuer shall indemnify the Note
Subscribers against any claim, demand, action, liability, damages, cost, loss 

  
 6 

 
or expense (including, without limitation, legal fees and any applicable value added tax) which it may incur as a result or arising out of or in relation to any failure to pay or delay in paying
any of the same. 
  

	2.5	 Note Subscriber’s rights and obligations 

 

	 	2.5.1.	 The obligations of each Note Subscriber under this Agreement are several. Failure by a Note Subscriber to
perform its obligations under this Agreement does not affect the obligations of any other Party. No Note Subscriber is responsible for the obligations of any other Note Subscriber under this Agreement. 

 

	 	2.5.2.	 The rights of each Note Subscriber under or in connection with this Agreement are separate and independent
rights and any debt arising under this Agreement to a Note Subscriber from the Issuer is a separate and independent debt in respect of which a Note Subscriber shall be entitled to enforce its rights in accordance with Clause 2.5.3 below. The rights
of each Note Subscriber include any debt owing to that Note Subscriber under this Agreement and, for the avoidance of doubt, the outstanding principal amount of any Note held by a Note Subscriber or any other amount owed by the Issuer which relates
to that Note or that Note Subscriber’s role under this Agreement is a debt owing to that Note Subscriber by the Issuer. 

  

	 	2.5.3.	 A Note Subscriber may separately enforce its rights under or in connection with this Agreement.

  

	3.	 CONDITIONS 

  

	3.1	 Conditions Precedent 

Each Note Subscriber will only be obliged to subscribe for the Notes if: 

 

	 	3.1.1.	 prior to or at the Closing, such Note Subscriber has received a copy of the Deed Poll and a copy of the Warrant
Instrument, in each case executed by the Issuer, and all the following documents and other evidence in form and substance satisfactory to it: 

  

	 	(a)	 a copy of the constitutional documents of the Issuer and any consents issued to the Issuer pursuant to the
Control of Borrowing (Jersey) Order 1958; 

  

	 	(b)	 a copy of a resolution of the board of directors of the Issuer (i) approving the terms of, and the
transactions contemplated by, the Transaction Documents and resolving that it execute the Transaction Documents, (ii) authorising a specified person or persons to execute the Transaction Documents on its behalf and (iii) authorising a
specified person or persons, on its behalf, to sign and/or despatch all documents and notices to be signed and/or despatched by it under or in connection with the Transaction Documents; 

 

	 	(c)	 a specimen of the signature of each person authorised by the resolution referred to in paragraph
(b) above; 

  

	 	(d)	 a certificate of an authorised signatory of the Issuer confirming that issuing the Notes would not cause any
borrowing, guaranteeing or similar limit binding on it to be exceeded; 

  

	 	(e)	 a certificate of an authorised signatory of the Issuer certifying that each copy document relating to it
specified in this Clause 3.1.1 is correct, complete and in full force and effect as at the Closing Date; 

  

	 	(f)	 a certified copy of the register of members of the Issuer as at the Closing Date; 

  
 7 

	 	(g)	 the warrant certificates in respect of the Warrants issued to the Note Subscribers; 

 

	 	(h)	 a copy of the Warrantholder Register of the Issuer dated the Closing Date; 

 

	 	(i)	 a legal opinion of Shearman & Sterling (London) LLP, legal advisers to the Note Subscribers in
England, as to enforceability of the Transaction Documents; 

  

	 	(j)	 a legal opinion of Walkers (Jersey) LLP, legal advisers to the Issuer in Jersey, as to capacity of the Issuer
to enter into the Transaction Documents; 

  

	 	(k)	 evidence that any process agent referred to in Clause 7.3 (Service of process) of this Agreement,
Condition 15(c) (Service of process) and Clause 9 of the Deed Poll has accepted its appointment; 

  

	 	(l)	 evidence that all fees payable on the Closing Date to the Note Subscribers will be paid on or prior to the
Closing Date; 

  

	 	(m)	 any information and evidence reasonably requested by such Note Subscriber in order to comply with Applicable
Laws in respect of anti-money laundering requirements and “know your customer” requirements; 

  

	 	(n)	 evidence that consent from the PIPE Investors to the issuance of the Notes has been obtained; and

  

	 	(o)	 evidence that any other shareholder approvals that may be required by the Issuer in connection with the
issuance of the Notes have been obtained. 

  

	 	3.1.2.	 on or prior to the date that is three (3) Business Days prior to the Closing Date, such Note Subscriber
has received all necessary information to enable it to make payment in accordance with Clause 4.2.3 (Payment of Issue Price). 

  

	 	3.1.3.	 on the Closing Date, no event has occurred which constitutes (after the issue of the Notes) an Event of Default
under condition 8 (Events of Default) in the Conditions, or a Default; 

  

	 	3.1.4.	 on the Closing Date, the representations to be made by the Issuer pursuant to Schedule 2
(Representations) on the Closing Date are true in all material respects or, if the representation is subject to materiality, in all respects; and 

  

	 	3.1.5.	 the Effective Time of the Business Combination has occurred. 

 

	3.2	 Non-Satisfaction/Waiver  

 

	 	3.2.1.	 Each Note Subscriber shall give notice to the Issuer upon receipt by it of a copy of the Deed Poll and a copy
of the Warrant Instrument, in each case executed by the Issuer, and all of the documents and other evidence listed in Clause 3.1.1(a) to (o) in form and substance satisfactory to it. 

 

	 	3.2.2.	 Subject to Clause 3.2.3, the Note Subscribers may at any time waive in whole or in part and conditionally or
unconditionally any of the conditions precedent set out in Clause 3.1 (Conditions Precedent) in writing. 

  

	 	3.2.3.	 The condition precedent set out in Clause 3.1.5 may only be waived by the Note Subscribers with the prior
written consent of the Issuer. 

  
 8 

	4.	 CLOSING 

  

	4.1	 Date and Place 

Subject to Clause 3 (Conditions), Closing shall take place on the Closing Date. 

 

	4.2	 Closing Events 

The closing of the issue shall take place on the Closing Date, whereupon: 

 

	 	4.2.1.	 Issue and Registration of Notes 

The Issuer shall issue the Notes and cause the Notes to be registered in the Register in the name of each Note Subscriber in respect of such
Note Subscriber’s holding of the Notes in accordance with Condition 3(a). 
  

	 	4.2.2.	 Delivery of Notes and copy of Register to the Note Subscribers 

The Issuer shall deliver: (i) a Certificate to each Note Subscriber as soon as reasonably practicable following the Closing Date; and
(ii) a PDF copy of the Register to each Note Subscriber on the Closing Date. 
  

	 	4.2.3.	 Payment of Issue Price 

Each Note Subscriber shall procure the payment of the Issue Price in respect of its proportion of the principal amount of the Notes to the
Issuer in US$ for immediate value to such account as the Issuer has designated to such Note Subscriber in writing at least three (3) Business Days prior to the Closing Date. 

 

	4.3	 Breach of Closing Obligations 

 

	 	4.3.1.	 If, at the Closing: 

  

	 	(a)	 the Issuer fails to issue the Notes and/or deliver the Certificate to a Note Subscriber in accordance with this
Clause 4 (Closing); or 

  

	 	(b)	 the Issuer fails to issue any or all of the Warrants to the Note Subscribers in accordance with the terms of
the Warrant Instrument; or 

  

	 	(c)	 any of the conditions precedent specified in Clause 3.1 (Conditions Precedent) have not been fulfilled
to such Note Subscriber’s satisfaction, 

 such Note Subscriber shall, at its election, be relieved of all further
obligations under this Agreement. 
  

	 	4.3.2.	 An election by a Note Subscriber under Clause 4.3.1 above shall not operate as a waiver of any rights such Note
Subscriber may have by reason of such failure or such non-fulfilment. 

  

	4.4	 Use of Proceeds 

 

	 	4.4.1.	 The Issuer will use the proceeds from the issue of the Notes for general corporate purposes.

  

	 	4.4.2.	 The Issuer will not directly or indirectly use the proceeds of the issue of the Notes, or lend, contribute or
otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity: 

  
 9 

	 	(a)	 to fund or facilitate any activities of or business with any person that, at the time of such funding or
facilitation, is a Sanctioned Person; 

  

	 	(b)	 to fund or facilitate any activities of or business in any Sanctioned Country; 

 

	 	(c)	 to make any payments to any governmental official or employee, political party, official of a political party,
candidate for political office, or anyone else acting in an official capacity to improperly obtain, retain or direct business, or to obtain any improper advantage in any other manner, 

in all cases, in such a way that will result in a violation by any person (including any person participating in the transaction, whether as
manager, advisor, investor or otherwise) of Sanctions or Anti-Corruption Laws. 
  

	5.	 REPRESENTATIONS  

 

	5.1	 The Issuer Representations  

The Issuer makes the representations and warranties set out in Schedule 2 (Representations) to each Note Subscriber on the date of this
Agreement (other than the representations and warranties set out in paragraphs 1.16(b), 1.16(c) and 1.16(d) of Schedule 2 (Representations), which are only made on the Closing Date) and, by reference to the facts and circumstances then
existing, on the Closing Date (other than the representation and warranty set out in paragraph 1.16(a), which is only made on the date of this Agreement) (for the purposes of which references in Schedule 2 (Representations) to the “date
of this Agreement” shall be deemed to be references to the Closing Date). 
  

	6.	 CONFIDENTIALITY  

 

	6.1	 Confidential Information  

Subject to 6.2 (Exclusions), each Party shall keep confidential the following (the “Confidential Information”): 

 

	 	6.1.1.	 all communications between the Parties relating to the Transaction Documents; 

 

	 	6.1.2.	 all information in whatever form and other materials supplied and received between the Parties relating to the
Transaction Documents which are either marked “confidential” or are by their nature intended to be for the knowledge of the recipient alone; and 

 

	 	6.1.3.	 any information relating to: 

 

	 	(a)	 the Transaction Documents; and 

 

	 	(b)	 the customers, directors, employees, business, assets or affairs of a Party or its Associated Companies and all
information concerning the business transactions and/or financial arrangements of a Party or its Associated Companies, 

and shall not use any Confidential Information for its own business purposes or disclose any Confidential Information to any third party
without the consent of the other Parties. 

  
 10 

	6.2	 Exclusions  

Clause 6.1 (Confidential Information) shall not prohibit the disclosure or use of any information if and to the extent: 

 

	 	6.2.1.	 the information is or becomes publicly available (other than by breach of this Agreement);

  

	 	6.2.2.	 the disclosure of such information is required in connection with the listing of the Notes;

  

	 	6.2.3.	 the relevant Party has given prior approval to the disclosure or use; 

 

	 	6.2.4.	 the information is information about the Group which the board of directors of the Issuer has confirmed in
writing to the Note Subscribers is not confidential; 

  

	 	6.2.5.	 the information is independently developed by a party after the date of this Agreement; 

 

	 	6.2.6.	 the disclosure or use is required by Applicable Laws, any governmental or regulatory body or any stock exchange
on which the shares of a Party or any of its Associated Companies is listed (including where this is required as part of any actual or potential offering, placing and/or sale of securities of that Party or any of its Associated Companies) or
requested by any court of competent jurisdiction or any relevant governmental, judicial, supervisory, regulatory or self-regulatory body including for the avoidance of doubt any disclosure required to be made in any prospectus, investor presentation
or any other document in connection with the Business Combination; 

  

	 	6.2.7.	 the disclosure or use is required for the purpose of any judicial proceedings arising out of this Agreement or
any documents to be entered pursuant to it; 

  

	 	6.2.8.	 the disclosure of information is to any tax authority to the extent such disclosure is reasonably required for
the purposes of the tax affairs of a Note Subscriber or any of its Associated Companies; 

  

	 	6.2.9.	 provided that in the event that any demand or request for disclosure of Confidential Information is made
pursuant to Clauses 6.2.6-6.2.8 above, either Party, as the case may be, shall (to the extent reasonably practicable to do so and, further, subject to such notification not being in breach of any applicable
confidentiality obligations) promptly notify the other Party of the existence of such request or demand and shall provide the other Party with a reasonable opportunity to seek an appropriate protective order or other remedy, which both Parties will
cooperate in seeking to obtain. In the event that such appropriate protective order or other remedy is not obtained, the Party whose Confidential Information is required to be disclosed shall or shall cause the other Party to furnish, or cause to be
furnished, only that portion of the Confidential Information that is legally required to be disclosed; 

  

	 	6.2.10.	 the disclosure by a Note Subscriber or its Associated Companies is to any of its Associated Companies and any
of its or their officers, directors, employees, professional advisers, auditors, partners and Representatives and is in respect of such information as such Note Subscriber or such Associated Companies shall consider reasonably appropriate, provided
that any person to whom the information is to be given pursuant to this Clause 6.2.10 is informed in writing of its confidential nature and that some or all of such information may be price-sensitive information provided further that that there
shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of the information or is otherwise bound by requirements of confidentiality in relation to such information; and

  

	 	6.2.11.	 the disclosure of information is on a confidential basis to a bona fide third party, professional advisers,
auditors, insurers or financiers of such third party wishing to acquire Notes from a Note Subscriber in accordance with the terms of the Transaction Documents to the extent that any such persons need to know the information for the purposes of
considering, evaluating, advising on or furthering the potential purchase, 

  
 11 

	 	
or to service providers and professional advisors who in their ordinary course of carrying out their services for such Note Subscriber or its Associated Companies may come into contact with
Confidential Information and who are bound by an obligation of confidentiality to such Note Subscriber or is otherwise subject to professional obligations to maintain the confidentiality of the information. 

 

	6.3	 Damages not an adequate remedy  

Without prejudice to any other rights or remedies which a Party may have, the Parties acknowledge and agree that damages would not be an
adequate remedy for any breach of this Clause 6 (Confidentiality) and the remedies of injunction, specific performance and other equitable relief are appropriate for any threatened or actual breach of any such provision and no proof of
special damages shall be necessary for the enforcement of the rights under this Clause 6 (Confidentiality). 
  

	6.4	 Duration of Confidentiality Obligations  

The obligations contained in this Clause 6 (Confidentiality) shall last for so long as a Note Subscriber holds Notes. 

 

	7.	 OTHER PROVISIONS  

 

	7.1	 Governing Law  

This Agreement, including any non-contractual obligations arising out of or in connection with it, are
governed by, and shall be construed in accordance with, English law. 
  

	7.2	 Jurisdiction  

 

	 	7.2.1.	 Subject to Clause 7.2.2, the courts of England and Wales are to have exclusive jurisdiction to settle any
disputes which may arise out of or in connection with this Agreement and any non-contractual obligations arising out of or in connection with it and accordingly any legal action or proceedings arising out of
or in connection with this Agreement or any such obligations (“Proceedings”) may be brought in such courts and each party irrevocably submits to the exclusive jurisdiction of such courts and waives any objection to Proceedings in such
courts whether on the ground of venue or on the ground that the Proceedings have been brought in an inconvenient forum. 

  

	 	7.2.2.	 Notwithstanding Clause 7.2.1, the Note Subscribers shall not be prevented from taking proceedings relating to a
dispute in any other courts with jurisdiction. To the extent allowed by law, the Note Subscribers may take concurrent proceedings in any number of jurisdictions. 

 

	7.3	 Service of process  

 

	 	7.3.1.	 Without prejudice to any other mode of service allowed under any relevant law, the Issuer:

  

	 	(a)	 irrevocably appoints Babylon Partners Limited with registered number 08493276, the registered office of which
is at 1 Knightsbridge Green, London, England, SW1X 7QA as its agent for service of process in relation to any proceedings before the English courts in connection with this Agreement; and 

 

	 	(b)	 agrees that failure by an agent for service of process to notify the Note Subscribers of the process will not
invalidate the proceedings concerned. 

  
 12 

	 	7.3.2.	 If any person appointed as an agent for service of process is unable for any reason to act as agent for service
of process, the Issuer shall immediately (and in any event within five (5) days of such event taking place) appoint another agent on terms acceptable to the Note Subscribers. Failing this, the Note Subscribers may appoint another agent for this
purpose. 

  

	7.4	 Notices  

  

	 	7.4.1.	 Any notice or other communication in connection with this Agreement shall be: 

 

	 	(a)	 in writing in English; and 

 

	 	(b)	 delivered by email. 

  

	 	7.4.2.	 A notice to the Issuer shall be sent to the following email address, or such other email address as the Issuer
may indicate by not less than five (5) Business Days’ notice in writing to the Note Subscribers from time to time: 

Email:                      
   legal-corporate@babylon.com 

Attention:                   General Counsel, Legal
Department 
  

	 	7.4.3.	 A notice to a Note Subscriber shall be sent to the email address identified with its name on its signature page
to this Agreement, or such other email address as such Note Subscriber may indicate by not less than five (5) Business Days’ notice to the Issuer in writing from time to time. 

 

	 	7.4.4.	 A notice shall be effective upon receipt and shall be deemed to have been received: upon generation of a
receipt notice by the recipient’s server, or if such notice is not so generated, upon the delivery to the recipient’s server. 

  

	 	7.4.5.	 Any electronic communication which becomes effective, in accordance with Clause 7.4.4 above, after 5.00 p.m. in
the place of receipt shall be deemed only to become effective on the following day. 

  

	7.5	 Release etc.  

Any liability owing from any Party under this Agreement may in whole or in part be released, compounded or compromised or time or indulgence
given by a Party in its absolute discretion without in any way prejudicing or affecting its rights against any other Party under the same or a like liability, whether joint and several or otherwise, or the rights of any other Party. 

 

	7.6	 Survival of Rights, Duties and Obligations  

 

	 	7.6.1.	 Termination of this Agreement for any cause shall not release a Party from any liability which at the time of
termination has already accrued to another Party or which thereafter may accrue in respect of any act or omission prior to such termination. 

  

	 	7.6.2.	 If a Party ceases to be a Party to this Agreement for any cause such Party shall not be released from any
liability which at the time of the cessation has already accrued to another Party or which thereafter may accrue in respect of any act or omission prior to such cessation. 

 

	7.7	 Waiver  

No failure of any Party to exercise, and no delay by it in exercising, any Right shall operate as a waiver of that Right, nor shall any single
or partial exercise of any Right preclude any other or further exercise of that Right or the exercise of any other Right. Any express waiver of any breach of this Agreement shall not be deemed to be a waiver of any subsequent breach. 

  
 13 

	7.8	 Variation  

No amendment to this Agreement shall be effective unless in writing and signed by or on behalf of each of the Parties. 

 

	7.9	 No assignment  

 

	 	7.9.1.	 Except as otherwise expressly provided in this Agreement, none of the Parties may without the prior written
consent of the others, assign, grant any security interest over, hold on trust or otherwise transfer the benefit of the whole or any part of this Agreement. 

  

	 	7.9.2.	 This Agreement shall be binding on the Parties and their respective successors and assigns.

  

	7.10	 Partial Invalidity  

If, at any time, any provision of this Agreement is or becomes illegal, invalid or unenforceable in any respect under any law of any
jurisdiction, neither the legality, validity or enforceability of the remaining provisions nor the legality, validity or enforceability of such provision under the law of any other jurisdiction will in any way be affected or impaired. 

 

	7.11	 Remedies and Waivers  

No failure to exercise, nor any delay in exercising, on the part of a Note Subscriber, of any Right under this Agreement shall operate as a
waiver, nor shall any single or partial exercise of any Right prevent any further or other exercise or the exercise of any other Right. The Rights provided in this Agreement are cumulative and not exclusive of any rights or remedies provided by law.

  

	7.12	 Counterparts  

This Agreement may be entered into in any number of counterparts, all of which taken together shall constitute one and the same instrument. Any
Party may enter into this Agreement by executing any such counterpart. 
  

	7.13	 Third Party Rights  

A person who is not a Party to this Agreement has no right to enforce any of its terms under the Contracts (Rights of Third Parties) Act 1999.

  

	7.14	 Survival  

The provisions of this Agreement shall continue in full force and effect notwithstanding the completion of the arrangements set out herein for
the issue of the Notes. 
 IN WITNESS WHEREOF THIS AGREEMENT has been duly executed on the date stated at the beginning of this Agreement. 

  
 14 

 SIGNATURE PAGES 

 

					
	 THE ISSUER
	  		  	
			
	 SIGNED on behalf of
	  	)	  	
		  	)	  	
		  	)	  	
		  	)	  	
	 BABYLON HOLDINGS LIMITED
	  	)	  	
		  	)
		  	)
		  	)

 [Signature Page to Note Subscription Agreement] 

					
	 THE NOTE SUBSCRIBERS
	  		  	
			
	 SIGNED on behalf of
	  	)	  	
	 	  	)	  	 
	 	  	)	  	 
	 	  	)	  	 
	 ALBACORE PARTNERS II INVESTMENT
	  	)	  	
	 HOLDINGS D DESIGNATED ACTIVITY
	  	)	  	
	 COMPANY and acknowledged for and on behalf
	  	)	  	
	 of AlbaCore Partners II ICAV 
	  	)	  	
	 	  	)	  	 
	 By: ALBACORE CAPITAL LLP as investment
	  	)	  	
	 manager for and on behalf of AlbaCore Capital
	  	)	  	
	 Limited as AIFM for AlbaCore Partners II
	  	)	  	
	 Investment Holdings D Designated Activity
	  	)	  	
	 Company and AlbaCore Partners II ICAV
	  	)	  	  

		  	)
		  	)
		  	)
		  	)
			
		  		  	     

 

 Notice Details 
  

	Address:	 10 EARLSFORT TERRACE, DUBLIN, DUBLIN, D02 T380, IRELAND (copy to: 55 St James’s Street, London, SW1A 1LA)

  

	Email:	 Notices@albacorecapital.com (with a copy to Ipeer@albacorecapital.com and
legal@albacorecapital.com) 

  

	Attention:	 Directors (copy to: Legal Department) 

[Signature Page to Note Subscription Agreement] 

					
	 SIGNED on behalf of
	  	)	  	
	 	  	)	  	 
	 	  	)	  	 
	 	  	)	  	 
	 ALBACORE PARTNERS III INVESTMENT
	  	)	  	
	 HOLDINGS DESIGNATED ACTIVITY COMPANY
	  	)	  	
	 and acknowledged for and on behalf of AlbaCore
	  	)	  	
	 Capital Group ICAV
	  	)	  	
	 	  	)	  	 
	 By: ALBACORE CAPITAL LLP as investment
	  	)	  	
	 manager for and on behalf of AlbaCore Capital
	  	)	  	
	 Limited as AIFM for AlbaCore Partners III
	  	)	  	
	 Investment Holdings Designated Activity Company
	  	)	  	
	 and AlbaCore Capital Group ICAV
	  	)	  	
	 	  	)	  	  

	 	  	)
	 	  	)
	 	  	)
	 	  	 	  	     

 

 Notice Details 
  

	Address:	 10 EARLSFORT TERRACE, DUBLIN, DUBLIN, D02 T380, IRELAND (copy to: 55 St James’s Street, London, SW1A 1LA)

  

	Email:	 Notices@albacorecapital.com (with a copy to Ipeer@albacorecapital.com and
legal@albacorecapital.com) 

  

	Attention:	 Directors (copy to: Legal
Department)                 

[Signature Page to Note Subscription Agreement] 

					
	 SIGNED on behalf of
	  	)	  	
		  	)	  	
		  	)	  	
		  	)	  	
	 ALBACORE STRATEGIC INVESTMENTS LP
	  	)	  	
	 acting by its Investment Manager, ALBACORE 
	  	)	  	
	 CAPITAL LLP
	  	)	  	  

		  	)
		  	)
		  	)
		  	)
		  		  	    
		  		  	     

 
  

 Notice Details 
  

	Address:	 Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman,
KY1-1104, Cayman Islands (copy to: 55 St James’s Street, London, SW1A 1LA) 

  

	Email:	 Notices@albacorecapital.com (with a copy to Ipeer@albacorecapital.com and
legal@albacorecapital.com) 

  

	Attention:	 Directors (copy to: Legal
Department)                 

[Signature Page to Note Subscription Agreement] 

 SCHEDULE 1 

THE NOTE SUBSCRIBERS 
  

			
	Name of Note Subscriber	 	Percentage of Principal Amount
		
	 AlbaCore Partners II Investment Holdings D
	 	 29 per cent.

	 Designated Activity Company
	 	
		
	 AlbaCore Partners III Investment Holdings
	 	 68.5 per cent.

	 Designated Activity Company
	 	
		
	 AlbaCore Strategic Investments LP
	 	 2.5 per cent.

		
	 Total
	 	 100 per cent.

  
 19 

 SCHEDULE 2 

REPRESENTATIONS 
  

	1.1	 Status  

  

	 	(a)	 It and each of its Subsidiaries is: 

 

	 	(i)	 a limited liability corporation, professional corporation, partnership, or company or a partnership with
limited liability; and 

  

	 	(ii)	 duly incorporated (or, as the case may be, organised) and validly existing under the laws of its jurisdiction
of its incorporation (or, as the case may be, organisation). 

  

	 	(b)	 It and each of its Subsidiaries has the power to own its assets and carry on its business as it is being
conducted. 

  

	1.2	 Binding Obligations  

Subject to the Legal Reservations, its obligations under this Agreement are, and upon due execution, its obligations under the Deed Poll and
upon issue, the Notes will be, legal, valid, binding and enforceable obligations and the Notes will constitute direct, unconditional, unsubordinated obligations of the Issuer ranking pari passu and rateably, without any preference amongst
themselves. 
  

	1.3	 Power and Authority  

It has the power to issue the Notes and enter into, perform and deliver, and has taken all necessary action to authorise its entry into,
performance and delivery of, each of the Transaction Documents and the Notes and to carry out the transactions contemplated by those documents and the Notes. 
  

	1.4	 Non-Conflict with other Obligations  

Subject to the Legal Reservations, the offer, sale, issue and distribution of the Notes and the entry into and performance by it of, and the
transactions contemplated by the Transaction Documents and the Notes do not contravene: 
  

	 	(a)	 any law or regulation applicable to it; 

 

	 	(b)	 its constitutional documents; or 

 

	 	(c)	 any agreement or instrument binding upon it or any member of the Group or any of its or their respective
assets, to an extent which has or is reasonably likely to have a Material Adverse Effect. 

  

	1.5	 Consents and Approvals  

 

	 	(a)	 All consents and approvals of any court, government department or other regulatory, administrative or
international body required by the Issuer for the execution and delivery of the Transaction Documents and the Notes and the offer, sale, issue and distribution of the Notes and the performance of the terms of the Transaction Documents and the Notes
by the Issuer have been obtained and are unconditional and in full force and effect. 

  

	 	(b)	 No further action or thing is required to be taken, fulfilled or done (including without limitation the
obtaining of any consent or licence or the making of any filing or registration) for the execution and delivery of the Transaction Documents and the Notes and the offer, sale, issue and distribution of the Notes and the performance of the terms of
the Transaction Documents and the Notes by the Issuer. 

  
 20 

	1.6	 Validity and Admissibility in Evidence  

 

	 	(a)	 Subject to the Legal Reservations, all Authorisations required: 

 

	 	(i)	 to enable it lawfully to offer, sell, issue and distribute the Notes and enter into, exercise its rights and
comply with its obligations in the Transaction Documents and the Notes; and 

  

	 	(ii)	 to make the Transaction Documents and the Notes admissible in evidence in Jersey, 

have been obtained or effected and are in full force and effect save where failure to do so would not have or would not reasonably be expected
to have a Material Adverse Effect. 
  

	 	(b)	 All Authorisations necessary for the conduct of the business, trade and ordinary activities of members of the
Group have been obtained or effected and are in full force and effect save where failure to do so would not have or would not reasonably be expected to have a Material Adverse Effect. 

 

	1.7	 No Default  

  

	 	(a)	 No Default is continuing or could reasonably be expected to result from the offer, sale, issue and distribution
of the Notes, or the entry into, the performance of, or any transaction contemplated by, any Transaction Document or the Notes. 

  

	 	(b)	 No other event or circumstance is outstanding which constitutes (or, with the expiry of a grace period, the
giving of notice, the making of any determination or any combination of the foregoing, would constitute) a default or termination event (however described) under any other agreement or instrument which is binding on it or any of its Subsidiaries or
to which its (or any of its Subsidiaries’) assets are subject which has or could reasonably be expected to have a Material Adverse Effect. 

  

	 	(c)	 No event has occurred which would constitute (after the issue of the Notes) an Event of Default under Condition
8 (Events of Default), or which, with the giving of notice or the lapse of time or other condition, would (after the issue of the Notes) could reasonably be expected to constitute an Event of Default. 

 

	1.8	 Governing Law and Enforcement  

 

	 	(a)	 Subject to the Legal Reservations, the choice of governing law of the Transaction Documents and the Notes will
be recognised and enforced in Jersey. 

  

	 	(b)	 Subject to the Legal Reservations, any judgment obtained in relation to a Transaction Document or the Notes in
the courts of England will be recognised and enforced in Jersey. 

  

	1.9	 Insolvency  

No: 
  

	 	(a)	 corporate action, legal proceeding or other procedure or step described in Conditions 8(g) to (i); or

  
 21 

	 	(b)	 creditors’ process described in Conditions 8(f) to (i), 

has been taken or, to the knowledge of the Issuer, threatened in relation to it or any Subsidiary and none of the circumstances described in
Condition 8(f) applies to it or a Subsidiary. 
  

	1.10	 No Misleading Information 

So far as the Issuer is aware, having made due and careful enquiry, all material information (taken as a whole) provided to the Note Subscriber
by the Issuer or its Representatives in connection with the Transaction Documents or the Notes on or before the date of this Agreement and not superseded before that date is true and accurate and not misleading in any material respect in the context
of the Transaction Documents and the Notes. 
  

	1.11	 Original Financial Statements 

Its audited financial statements for the financial year ended 31 December 2020 give a true and fair view of its financial condition and
results of operations during the relevant financial year. 
  

	1.12	 No Proceedings Pending or Threatened 

No litigation, arbitration or administrative proceedings or investigations of, or before, any court, arbitral body or agency which are
reasonably likely to be adversely determined and, if adversely determined, would have or would be reasonably likely to have a Material Adverse Effect have (as far as the Issuer is aware having made due and careful enquiry) been started, pending or
threatened in writing. 
  

	1.13	 Compliance with laws 

It and each of its Subsidiaries is in compliance with all laws and regulations (applicable to it in its relevant jurisdiction where non-compliance would reasonably be likely to have a Material Adverse Effect. 
  

	1.14	 Taxation 

  

	 	(a)	 Under the laws of its relevant jurisdiction and the United Kingdom it is not necessary that the Transaction
Documents or the Notes be filed, recorded or enrolled with any court or other authority in that jurisdiction, or that any stamp, registration, notarial or similar Tax or fees be paid on or in relation to the Transaction Documents or the Notes or the
transactions contemplated by the Transaction Documents or the Notes. 

  

	 	(b)	 It is not (and none of its Subsidiaries is) materially overdue in the filing of any Tax returns and it is not
(and none of its Subsidiaries is) overdue in the payment of any amount in respect of Tax which has or is reasonably likely to have a Material Adverse Effect. 

 

	1.15	 Legal and Beneficial Ownership 

It and each of its Subsidiaries has good, valid and marketable title to, or valid leases or licences of, or is otherwise entitled to use, all
material assets necessary for the conduct of the business as it is presently being conducted, where failure to do so would have or would reasonably be expected to have a Material Adverse Effect. 

 

	1.16	 Shares 

  

	 	(a)	 As at the date of this Agreement, the Issuer has the number of fully paid and issued Shares as set out in Part
1 of Schedule 3. 

  
 22 

	 	(b)	 As at the Closing Date: 

 

	 	(i)	 the Issuer has the number of fully paid and issued Shares as set out in the certified share register excerpt
delivered pursuant to Clause 3.1.1(f); and 

  

	 	(ii)	 the Issuer’s authorised share capital is as set out in Part 2 of Schedule 3. 

 

	 	(c)	 As at immediately prior to the Effective Date of the Business Combination, the fully diluted share capital of
the Issuer was 351,499,956 ordinary shares of US$0.0000422573245084686 each in the capital of the Company (comprised of 310,662,380 class A ordinary shares of US$0.0000422573245084686 each in the capital of the Company and 40,837,576 class B
ordinary shares of US$0.0000422573245084686 each in the capital of the Company), assuming at such time the exercise in full of any options or warrants and the conversion of any convertible securities (excluding for the avoidance of doubt any Shares
or warrants, or rights to subscribe for Shares or warrants, to be issued or granted in connection with the Business Combination or on the Closing Date). 

  

	 	(d)	 As at the Closing Date, the Issuer has available for issue and authority to allot, free from pre-emption rights, sufficient share capital to enable the rights attaching to the Warrants to be satisfied in full pursuant to the Warrants, and all other rights of subscription and conversion into Shares to be
satisfied in full in accordance with their terms. 

  

	 	(e)	 The Shares to be issued upon exercising the Warrants will be fully paid and will not be subject to calls for
further funds. 

  

	 	(f)	 The Shares to be issued upon exercising the Warrants will rank pari passu with the then outstanding Shares of
the same class. 

  

	1.17	 Intellectual Property 

The Intellectual Property required in order to conduct the business of the Group as is presently being conducted: 

 

	 	(a)	 is beneficially owned by or licensed to members of the Group on arm’s length terms free from any licences
to third parties which are materially prejudicial to the use of that Intellectual Property and will not be adversely affected by the transactions contemplated by the Transaction Documents or the Notes in each case to an extent which would reasonably
be expected to have a Material Adverse Effect; and 

  

	 	(b)	 has not lapsed or been cancelled in any respect which has or could reasonably be expected to have a Material
Adverse Effect and all steps have been taken to protect and maintain such Intellectual Property, including, without limitation, paying renewal fees where failure to do so would reasonably be expected to have a Material Adverse Effect.

  

	1.18	 Anti-Corruption Laws, Anti-Money Laundering Laws and Sanctions Representation 

 

	 	(a)	 None of the Issuer or any of its Subsidiaries, nor to the Issuer’s knowledge any of their respective
directors or officers: 

  

	 	(i)	 is a Sanctioned Person; or 

 

	 	(ii)	 has engaged or is engaged, whether directly or indirectly, in any activity: 

 

	 	(A)	 which involves any Sanctioned Person and/or Sanctioned Country and which, in all cases, could reasonably be
expected to result in any person being in breach of Sanctions or becoming a Sanctioned Person; or 

  
 23 

	 	(B)	 in the last three years which has violated applicable Anti-Corruption Laws, Anti-Money Laundering Laws or
Sanctions; or 

  

	 	(iii)	 has in the last three years received notice or is otherwise aware of any claim, proceeding or regulatory
authority-initiated investigation involving it with respect to a breach of applicable Anti-Corruption Laws, Anti-Money Laundering Laws, or Sanctions. 

  

	 	(b)	 Nothing in this paragraph 1.18 shall create or establish an obligation or right for any entity to the extent
that, by agreeing to it, complying with it, exercising it, having such obligation or right, or otherwise, a member of the Group would be placed in violation of any law applicable to it. 

 

	1.19	 Private Offering by the Issuer  

 

	 	(a)	 Neither the Issuer nor anyone acting on its behalf has offered or sold the Notes or any similar securities to,
or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect of the Notes or any similar securities with, any person other than the Note Subscribers, each of which has been offered the Notes privately for
investment. 

  

	 	(b)	 Neither the Issuer nor anyone acting on its behalf has taken, or will take, any action that would require the
Issuer to publish a prospectus pursuant to the Prospectus Regulation, the UK Prospectus Regulation or the FSMA in respect of the issuance or sale of the Notes. 

 

	 	(c)	 The consent of the Jersey Financial Services Commission pursuant to Article 4 of the Control of Borrowing
(Jersey) Order 1958 is not required in respect of the issue of the Notes, as the number of persons in whose names the Notes are or are to be registered does not exceed ten (10) (joint holders being counted as one person). 

 

	 	(d)	 A copy of this Agreement is not required to be delivered to the registrar of companies in Jersey (the
“Jersey Registrar”) in accordance with Article 5 of the Companies (General Provisions) (Jersey) Order 2002, nor is the consent of the Jersey Registrar required in connection with its circulation. 

 

	1.20	 Absence of Directed Selling Efforts  

Neither it, nor any of its Affiliates, nor any person acting on its or their behalf has engaged, or will engage, in any “directed selling
efforts” (as defined in Regulation S under the Securities Act) with respect to the Notes. 
  

	1.21	 No Registration Required  

 

	 	(a)	 The Notes issued will not be registered under the Securities Act nor registered or qualified under any state
securities or “Blue Sky” laws of the states of the United States and accordingly, it acknowledges that the Notes may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to,
the registration requirements of the Securities Act; 

  

	 	(b)	 Neither the Issuer nor any of its Affiliates, nor any person acting on its or their behalf (i) has made or
will make offers or sales of any security, or solicited offers to buy, or otherwise negotiated in respect of, any security of a type or in a manner which would be integrated with the sale of the Notes, under circumstances that would require the

  
 24 

	 	
registration of the Notes under the Securities Act; or (ii) has engaged, or will engage, in any form of general solicitation or general advertising (within the meaning of Rule 502(c) under
the Securities Act) in connection with any offer or sale of the Notes in the United States. 

  

	 	(c)	 Neither it, nor any of its Affiliates, nor any person acting on any of their behalf has made or will make
offers or sales of any securities under circumstances that would require the registration of the offer or sale of any Notes under the Securities Act. 

  

	1.22	 Regulation S Compliance 

It is a “foreign issuer” (as such term is defined in Regulation S) which reasonably believes that there is no “substantial U.S.
market interest” (as such term is defined in Regulation S) in its debt securities. 

  
 25 

 SCHEDULE 3 

SHARE CAPITAL OF THE ISSUER 
 Part 1
– Issued Shares as at the date of this Agreement 
  

			
	 Class of Shares
	  	 Total number of issued Shares as at the date

of the Agreement

	 A ordinary shares with a par value of
	  	135,136,000
	 US$0.00001277 each
	  	
		
	 B ordinary shares with a par value of
	  	681,811,437
	 US$0.00001277 each
	  	
		
	 Series C preferred shares with a par value of
	  	293,077,489
	 US$0.00001277 each
	  	
		
	 G1 ordinary redeemable shares with a par value
	  	10,150,395
	 of US$0.00001277 each
	  	

 Part 2 – Authorised share capital of the Issuer as at the Closing Date 

US$409,896.05 divided into: 
  

	 	1.	 6,500,000,000 Class A Ordinary Shares with a par value of US$0.0000422573245084686 each;

  

	 	2.	 3,100,000,000 Class B Ordinary Shares with a par value of US$0.0000422573245084686 each; and

  

	 	3.	 100,000,000 Deferred Shares with a par value of US$0.0000422573245084686 each. 

  
 26EX-4.6

 Exhibit 4.6 

EXECUTION VERSION 
 WARRANT INSTRUMENT

 4 NOVEMBER 2021 

BABYLON HOLDINGS LIMITED 
  

 
 Allen & Overy LLP 

 

 CONTENTS 
  

							
	Clause	  	 	  	Page	 
			
	 1.
	  	 Interpretation
	  	 	1	 
	 2.
	  	 Constitution, Grant and Form of Warrants and Register
	  	 	5	 
	 3.
	  	 Exercise of Subscription Entitlement
	  	 	6	 
	 4.
	  	 Lapse of Subscription Entitlement
	  	 	6	 
	 5.
	  	 Procedures on an Exercise Event
	  	 	6	 
	 6.
	  	 Issue of Warrant Shares
	  	 	8	 
	 7.
	  	 Cash Redemption
	  	 	9	 
	 8.
	  	 Adjustment of Subscription Entitlement
	  	 	10	 
	 9.
	  	 Adjustment of Warrant Shares
	  	 	11	 
	 10.
	  	 Determination by Auditors or Independent Financial Adviser
	  	 	11	 
	 11.
	  	 Undertakings and Information
	  	 	13	 
	 12.
	  	 Winding Up
	  	 	13	 
	 13.
	  	 Transfer of Warrants
	  	 	14	 
	 14.
	  	 Meetings of Warrantholders
	  	 	14	 
	 15.
	  	 Warrantholders’ Representative
	  	 	14	 
	 16.
	  	 Tax
	  	 	14	 
	 17.
	  	 Payments
	  	 	14	 
	 18.
	  	 Variation
	  	 	15	 
	 19.
	  	 Severance
	  	 	15	 
	 20.
	  	 Third Party Rights
	  	 	15	 
	 21.
	  	 Notices
	  	 	16	 
	 22.
	  	 Governing Law and Jurisdiction
	  	 	16	 
	 23.
	  	 Process Agent
	  	 	16	 
		
	 Schedule
	  			
			
	 1.
	  	 Initial Warrantholders
	  	 	17	 
	 2.
	  	 Form of Warrant Certificate
	  	 	18	 
	 3.
	  	 Form of Exercise Notice
	  	 	19	 
	 4.
	  	 The Conditions
	  	 	21	 
		
	 Signatories
	  	 	26	 

 THIS INSTRUMENT (this Instrument) is executed as a deed poll on 4 November 2021 by
BABYLON HOLDINGS LIMITED, a public limited company incorporated and registered in Jersey with registered number 115471, the registered office of which is at 13 Castle Street, St Helier, Jersey, JE1 1ES (the Company). 

WHEREAS: 
  

	(A)	 The Company has entered into a note subscription agreement with the Initial Warrantholders on 8 October
2021 in connection with the issue of up to US$200,000,000 unsecured notes due 2026 (the Notes) pursuant to a notes deed poll dated on or around the date of this Instrument (the Notes Deed Poll) and the Warrants constituted by this
Instrument. 

  

	(B)	 The Warrants have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the
Securities Act), and may not be offered or sold directly or indirectly within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The issue of the
Warrants is being made by the Company in a private placement transaction in a manner not requiring registration under the Securities Act. 

  

	(C)	 The Company, by resolution of its board of directors passed on 7 October 2021, has authorised the issue of
the Warrants to subscribe for the Warrant Shares on the terms set out in this Instrument, which shall take effect as a deed poll. 

NOW THIS INSTRUMENT WITNESSES AND IT IS DECLARED as follows: 
  

	1.	 INTERPRETATION 

 

	1.1	 The definitions and rules of interpretation in this Clause apply in this Instrument. 

 Adjustment has the meaning given in Clause 8.1. 

Affiliate means, in relation to any person, a subsidiary of that person or a holding company of that person or any other subsidiary of
that holding company. 
 AlbaCore means AlbaCore Capital LLP, a limited liability partnership registered in England with number
OC412196 and having its registered office at 55 St. James’s Street, London, SW1A 1LA.  
 Articles means the memorandum
and articles of association of the Company as amended or superseded from time to time. 
 Associated Company means in relation to a
Warrantholder, (a) any of its Affiliates, or any fund, partnership, special purpose vehicle or similar vehicle (the Entity) in respect of which the person or any of its Affiliates is (i) a limited partner or the general partner; or
(ii) an investment manager; or (iii) directly or indirectly Controls the Entity or (b) any investor in an Entity or such person, and for the purposes of this definition, Control means in relation to any person, where a person
has direct or indirect control over more than 50% of the voting share capital of the relevant person. 
 Auditors means the auditors
of the Company from time to time.  
 Board means the board of directors of the Company from time to time. 

Business Day means a day (other than a Saturday, Sunday or public holiday) on which commercial banks and foreign exchange markets are
open for business in Dublin, London, New York and Jersey.  
 Cash Redemption Election has the meaning given in Clause 7.1.

  
 1 

 Cash Redemption Payment has the meaning given in Clause 7.1. 

Certificate means a certificate in respect of Warrants, substantially in the form set out in Schedule 2.  

Change of Control has the meaning given in the Notes Deed Poll.  

Change of Control Exercise Event has the meaning given in Clause 3.2. 

Class A Ordinary Shares means the class A ordinary shares of US$0.0000422573245084686 each in the capital of the
Company from time to time and, if there is a sub-division, consolidation or reclassification of such shares, the shares resulting from that event, having the rights and being subject to the restrictions set
out in the Articles. 
 Closing Price means, in respect of a Class A Ordinary Share on any Trading Day, the closing price on such
Trading Day on the Relevant Stock Exchange of a Class A Ordinary Share published by or derived from Bloomberg page HP (or any successor page) (setting Last Price, or any other successor setting and using values not adjusted for any event
occurring after such Trading Day; and for the avoidance of doubt, all values will be determined with all adjustment settings on the DPDF Page, or any successor or similar setting, switched off) in respect of the Relevant Stock Exchange and in
respect of such Class A Ordinary Shares, as determined by the Company, provided that if on any such Trading Day (for the purpose of this definition, the Affected Day) such price is not available or cannot otherwise be determined as
provided above, the Closing Price of a Class A Ordinary Share in respect of such Trading Day shall be the Closing Price, determined as provided above, on the immediately preceding Trading Day on which the same can be so determined, and further
provided that if such immediately preceding Trading Day falls prior to the fifth day before the Affected Day, an Independent Financial Adviser shall determine the Closing Price in good faith. 

COBO Order means the Control of Borrowing (Jersey) Order 1958. 

Conditions means the terms and conditions set out in Schedule 4 (subject to any alterations made in accordance with this Instrument).

 Early Redemption Exercise Event has the meaning given in Clause 3.3. 

Encumbrances means any security interests, claims, charges, mortgages, liens, options,
pre-emption or other third-party rights, or agreements, arrangements or obligations to create any of the foregoing.  

Equity Shares means shares in the equity share capital of the Company (or, following an Adjustment, the relevant member of the Group)
from time to time. 
 Equivalent Proportion means a number of Warrants (rounded to the nearest whole Warrant) calculated by
multiplying the total number of Warrants held by a Warrantholder by the proportion that the principal amount of the Notes being transferred by that Warrantholder bears to the total principal amount of the Notes held by that Warrantholder immediately
prior to such transfer. 
 Exercise Completion Date has the meaning given in Clause 5.1(c). 

Exercise Event means a Mandatory Exercise Event, a Change of Control Exercise Event, an Early Redemption Exercise Event and/or a Final
Maturity Exercise Event. 
 Exercise Notice means a notice in writing in the form, or substantially in the form, set out in Schedule
3. 
 Exit means any Change of Control or de-listing of the Equity Shares from the New
York Stock Exchange. 

  
 2 

 Final Maturity Date has the meaning given in the Notes Deed Poll.  

Final Maturity Exercise Event has the meaning given in Clause 3.4. 

Group means the Company, any subsidiary undertaking or any holding company of the Company and any other subsidiary undertaking from time
to time of a holding company of the Company.  
 holding company has the meaning given in Clause 1.12. 

Initial Warrantholders means the persons whose names and addresses are set out in Schedule 1. 

Independent Financial Adviser means an independent financial advisory firm or an independent investment bank, in each case of
international repute. 
 Issuer Redemption Notice has the meaning given in the Notes Deed Poll.  

Law means the Companies (Jersey) Law 1991 (as amended). 

Mandatory Exercise Event has the meaning given in Clause 3.1.  

Notes has the meaning given in Recital (A). 

Notes Deed Poll has the meaning given in Recital (A). 

Permitted Transferee means a Related Fund of a Warrantholder or an Affiliate of a Warrantholder.  

Redemption Date has the meaning given in the Notes Deed Poll. 

Redemption Notice has the mean given in the Notes Deed Poll. 

Register means a register of Warrantholders referred to in Clause 2.5, and kept and maintained in accordance with paragraph 1 of
Schedule 4. 
 Registered Office means the registered office of the Company from time to time.  

Related Fund has the meaning given in the Notes Deed Poll. 

Relevant Stock Exchange means in respect of the Class A Ordinary Shares the principal stock exchange or securities market on which
the Class A Ordinary Shares are listed, admitted to trading or quoted or dealt in. 
 Restricted Period means the period
commencing on the date of this Instrument and ending on the date that is 18 calendar months from the date of this Instrument. 

Subscription Entitlement has the meaning given in Clause 2.4. 

Subscription Price means, subject to Clause 8, US$0.0000422573245084686 per Warrant Share.  

subsidiary has the meaning given in Clause 1.12. 

Tax Deduction means a withholding or deduction for or on account of, any present or future taxes, duties, assessments or governmental
charges of whatever nature. 
 Tax Redemption Date has the meaning given in the Notes Deed Poll.  

Tax Redemption Notice has the meaning given in the Notes Deed Poll. 

  
 3 

 Trading Day means a day on which the Relevant Stock Exchange is open for business and
on which Class A Ordinary Shares may be dealt in (other than a day on which the Relevant Stock Exchange is scheduled to or does close prior to its regular closing time). 

Transfer has the meaning given in paragraph 2.1 of Schedule 4. 

Value Cap means, subject to Clause 8, US$15.00 per Class A Ordinary Share.  

Value Cap Adjustment has the meaning given in subparagraph (ii) of Clause 8.1. 

Value Cap Warrant Shares Adjustment means any adjustment to the number of Warrant Shares to which a Warrantholder is entitled per
Warrant held by it made in accordance with Clause 9.  
 Warrant means a private warrant to subscribe for one Warrant Share, on
the terms and subject to the conditions of this Instrument. 
 Warrant Shares means the Class A Ordinary Shares or, following an
Adjustment, such other shares in the capital of a member of the Group as may be required pursuant to the terms of an Adjustment, in each case issued to the Warrantholder following exercise of the Warrants in accordance with the terms of this
Instrument (and Warrant Share means any of them). 
 Warrantholder means the person or persons in whose name(s) a Warrant is
registered from time to time as evidenced by the Register. 
 Warrantholder Consent means prior consent in writing from a
Warrantholder Majority, which consent may be communicated to the Company by the Warrantholders’ Representative on behalf of the Warrantholders.  

Warrantholder Majority means one or more Warrantholder(s) for the time being holding outstanding Warrants representing not less than 50%
in nominal value of the Warrant Shares subject to an outstanding Subscription Entitlement. 
 Warrantholders’ Representative
means AlbaCore or such other person as the Warrantholder Majority may appoint by giving notice to the Company. 
  

	1.2	 Clause, Schedule and paragraph headings shall not affect the interpretation of this Instrument.

  

	1.3	 References to Clauses and Schedules are to the Clauses of and Schedules to this Instrument, and references to
paragraphs are to paragraphs of the relevant Schedule. 

  

	1.4	 The Schedules form part of this Instrument and shall have effect as if set out in full in the body of this
Instrument. Any reference to this Instrument includes the Schedules. 

  

	1.5	 A reference to this Instrument is a reference to this Instrument as varied or novated in accordance with
its terms from time to time. 

  

	1.6	 Unless the context otherwise requires, words in the singular shall include the plural and the plural shall
include the singular. 

  

	1.7	 Unless the context otherwise requires, a reference to one gender shall include a reference to the other
genders. 

  

	1.8	 A reference to writing or written includes e-mail.

  
 4 

	1.9	 Any words following the terms including, include, in particular, for example or any
similar expression shall be construed as illustrative and shall not limit the sense of the words, description, definition, phrase or term preceding those words. 

 

	1.10	 A reference to a statute or statutory provision is a reference to it as amended or re-enacted from time to time and shall include all subordinate legislation made from time to time under that statute or statutory provision. 

 

	1.11	 A reference to US$, $ or US dollars shall be dollars of the United States of America.

  

	1.12	 A company is a subsidiary of another company (its holding company) if that other company,
directly or indirectly, through one or more subsidiaries: 

  

	 	(a)	 holds a majority of the voting rights in it; 

 

	 	(b)	 is a member or shareholder of it and has the right to appoint or remove a majority of its board of directors or
equivalent managing body; 

  

	 	(c)	 is a member or shareholder of it and controls alone, or pursuant to an agreement with other shareholders or
members, a majority of the voting rights in it; or 

  

	 	(d)	 has the right to exercise a dominant influence over it, for example by having the right to give directions with
respect to its operating and financial policies, with which directions its directors are obliged to comply. 

  

	2.	 CONSTITUTION, GRANT AND FORM OF WARRANTS AND REGISTER 

 

	2.1	 The Company hereby constitutes 1,757,499 Warrants to subscribe for the Warrant Shares on the terms and subject
to the conditions of this Instrument. 

  

	2.2	 The Warrants shall be issued in registered form on the date of this Instrument to the Initial Warrantholders in
the respective numbers set out opposite their names in Schedule 1. 

  

	2.3	 The Warrants shall be issued subject to the Articles and otherwise on the terms and subject to the conditions
of this Instrument (including the Conditions) which are binding on the Company and each Warrantholder, and all persons claiming through or under them respectively. The Warrants shall not be issued to more than ten Warrantholders at any time without
the consent of the Jersey Financial Services Commission under the COBO Order. 

  

	2.4	 Each Warrant shall confer the right on the Warrantholder holding such Warrant to receive one Warrant Share,
subject to any Adjustment or any Value Cap Adjustment in accordance with Clause 8 and to any Value Cap Warrant Shares Adjustment in accordance with Clause 9 (the Subscription Entitlement). Any Warrant Shares issued upon the exercise of the
Subscription Entitlement shall be issued at the Subscription Price per Warrant Share and credited as fully paid on the terms and subject to the conditions of this Instrument. Notwithstanding the foregoing, upon an Exercise Event, the Company may at
its absolute discretion elect to satisfy the Subscription Entitlement in whole or in part by making a Cash Redemption Payment in accordance with Clause 7. 

  

	2.5	 The Company shall procure that the Register is maintained, and Certificates are issued, in accordance with the
Conditions. 

  

	2.6	 During the Restricted Period, no Warrantholder shall be permitted to enter into a hedging transaction in
respect of its risk or exposure under the Warrants (except for currency management operations which are carried out in the ordinary course of business and for non-speculative purposes only).

  
 5 

	3.	 EXERCISE OF SUBSCRIPTION ENTITLEMENT 

 

	3.1	 The Subscription Entitlement of each Warrantholder shall be deemed to be automatically and irrevocably
exercised (in whole and not in part only) at 11 am (New York time) on the first date following which the Closing Price of the Class A Ordinary Shares has equalled or exceeded the Value Cap for any 20 Trading Days within any 30-Trading Day period commencing on the first Trading Day following the expiry of the Restricted Period (such date, a Mandatory Exercise Event). For the avoidance of doubt, no Mandatory Exercise Event may
occur during the Restricted Period. 

  

	3.2	 In the event that a Redemption Notice is given pursuant to the Notes Deed Poll in connection with a Change of
Control, the Subscription Entitlement of each Warrantholder shall, unless agreed otherwise between the Company and the Warrantholder Majority, be deemed to be automatically and irrevocably exercised (in whole and not in part only) at 11 am (New York
time) on the date of receipt by the Company of such Redemption Notice (a Change of Control Exercise Event). 

  

	3.3	 In the event that an Issuer Redemption Notice or Tax Redemption Notice is given pursuant to the Notes Deed Poll
at any time following the date of this Instrument, the Subscription Entitlement of each Warrantholder shall, unless agreed otherwise between the Company and the Warrantholder Majority, be deemed to be automatically and irrevocably exercised (in
whole and not in part only) at 11 am (New York time) on the Redemption Date or Tax Redemption Date (as applicable) (an Early Redemption Exercise Event). 

 

	3.4	 If and to the extent the Subscription Entitlement has not been exercised prior to the Final Maturity Date, the
Subscription Entitlement shall, unless agreed otherwise between the Company and the Warrantholder Majority, be deemed to be automatically and irrevocably exercised (in whole and not in part only) at 11 am (New York time) on the Final Maturity Date
(a Final Maturity Exercise Event). 

  

	4.	 LAPSE OF SUBSCRIPTION ENTITLEMENT 

Subject to Clause 12, if an effective resolution is passed or an order is made for the winding up of the Company (otherwise than for the
purposes of a reconstruction, consolidation, amalgamation or merger on terms previously sanctioned by a Warrantholder Consent), the Subscription Entitlement and the Warrants to which they relate shall automatically lapse and cease to be exercisable
on the date of that resolution or order. 
  

	5.	 PROCEDURES ON AN EXERCISE EVENT 

 

	5.1	 As soon as reasonably practicable following a Mandatory Exercise Event or as soon as reasonably practicable
following receipt of a Redemption Notice in respect of a Change of Control, and at least ten Business Days prior to an Early Redemption Exercise Event or a Final Maturity Exercise Event, the Company shall issue an Exercise Notice to the
Warrantholders’ Representative (in accordance with the provisions of Clause 21) which shall specify: 

  

	 	(a)	 in the event of a Mandatory Exercise Event or a Change of Control Exercise Event, the date and time on which
the Subscription Entitlement was deemed to be automatically and irrevocably exercised in accordance with Clause 3.1 or 3.2 as applicable or, in the event of an Early Redemption Exercise Event or a Final Maturity Exercise Event, the date and time on
which the Subscription Entitlement shall be deemed to be automatically and irrevocably exercised in accordance with Clause 3.3 or 3.4 as applicable; 

  

	 	(b)	 whether the Company will satisfy the Subscription Entitlement: 

 

	 	(i)	 by issuing Warrant Shares; or 

 

	 	(ii)	 by making a Cash Redemption Payment; or 

  
 6 

	 	(iii)	 by a combination of (i) and (ii), provided that: 

 

	 	(A)	 the proportions in which the Company satisfies the Subscription Entitlement by issuing Warrant Shares and by
making a Cash Redemption Payment respectively shall be determined at the absolute discretion of the Company and shall be set out in the Exercise Notice; and 

  

	 	(B)	 an amount equal to the aggregate Subscription Price for the specified number of Warrant Shares to be issued
(rounded up to the nearest US$0.01) shall be deducted from the Cash Redemption Payment in lieu of payment of the Subscription Price to the Company in cash and such deduction shall be set out in the Exercise Notice; 

 

	 	(c)	 the date on which the Company shall issue the Warrant Shares and/or make the Cash Redemption Payment (as
applicable), which shall be: 

  

	 	(i)	 in respect of a Mandatory Exercise Event, a date within a period of 28 days from the Mandatory Exercise Event;
or 

  

	 	(ii)	 in respect of a Change of Control Exercise Event, as soon as reasonably practicable following the Change of
Control Exercise Event; or 

  

	 	(iii)	 in respect of an Early Redemption Exercise Event, the Redemption Date or Tax Redemption Date (as applicable);
or 

  

	 	(iv)	 in respect of a Final Maturity Exercise Event, the Final Maturity Date, 

provided that in all cases such date shall be a Business Day (and if such date is not a Business Day, the next following day that is a Business
Day) (the Exercise Completion Date); 
  

	 	(d)	 where the Company is satisfying the Subscription Entitlement (in whole or in part) by issuing Warrant Shares,
the number of Warrant Shares to be issued to each Warrantholder, including (where applicable), reasonable detail of any Value Cap Warrant Shares Adjustment made in accordance with Clause 9; 

 

	 	(e)	 where the Company is satisfying the Subscription Entitlement in whole or in part by making a Cash Redemption
Payment, the amount of the Cash Redemption Payment to be made to each Warrantholder including reasonable detail of the calculation of such Cash Redemption Payment; and 

 

	 	(f)	 where applicable, reasonable detail of the basis of determination and/or calculation of the Closing Price.

  

	5.2	 Promptly (and in any event within 10 Business Days or, if earlier, at least 2 Business Days prior to the
Exercise Completion Date) following receipt of the Exercise Notice by the Warrantholders’ Representative, each Warrantholder shall: 

  

	 	(a)	 deliver to the Company at its Registered Office any Certificate(s) issued by the Company in respect of the
Warrants held by such Warrantholder (or deed of indemnity in favour of the Company on such terms as the Company may reasonably require in the case of any lost, damaged or destroyed Certificates); 

 

	 	(b)	 where the Company is satisfying the Subscription Entitlement in whole by issuing Warrant Shares pursuant to
Clause 5.1(b)(i), pay to the Company (or procure payment to the Company of) the aggregate Subscription Price applicable to the Warrant Shares to be issued to it as specified in the Exercise Notice in US dollars in accordance with Clause 17; and

  
 7 

	 	(c)	 where the Company is satisfying the Subscription Entitlement in whole or in part by making a Cash Redemption
Payment, notify the Company of its account details for the making of the Cash Redemption Payment in accordance with Clause 17.3. 

  

	5.3	 Once delivered, an Exercise Notice shall be irrevocable (except with the consent of the Warrantholder Majority,
which consent may be withheld or conditioned in the Warrantholder Majority’s absolute discretion). 

  

	5.4	 Where the Exercise Notice specifies that the Company is satisfying the Subscription Entitlement (in whole or in
part) by issuing Warrant Shares, on the Exercise Completion Date, each Warrantholder shall be deemed to subscribe for such Warrant Shares at the Subscription Price per Warrant Share, which shall be issued to the Warrantholder by the Company free
from any Encumbrances (save as set out in the Articles) and credited by the Company as being fully paid. 

  

	6.	 ISSUE OF WARRANT SHARES 

 

	6.1	 Subject to the Articles, to any applicable legal and regulatory requirements and to compliance by the relevant
Warrantholder(s) with the provisions of Clause 5.2, completion of the allotment and issue of Warrant Shares shall take place on the Exercise Completion Date or at such earlier time as the Board may determine (acting in its absolute discretion).

  

	6.2	 On the Exercise Completion Date, the Company shall promptly, subject to the Law and to the Articles and the
Warrantholder’s compliance with its applicable obligations in Clause 5.2: 

  

	 	(a)	 allot and issue to the Warrantholder the number of Warrant Shares in respect of which its Subscription
Entitlement has been exercised; 

  

	 	(b)	 procure the entry of the Warrantholder in the Company’s register of members as the holder of the number of
Warrant Shares issued to it and deliver a copy thereof to the Warrantholder; and 

  

	 	(c)	 to the extent that the Warrant Shares are to be held in certificated form, deliver to the Warrantholder a duly
executed share certificate for the number of Warrant Shares issued to it that will be so held. 

  

	6.3	 The Warrant Shares issued under Clause 6.2(a) shall: 

 

	 	(a)	 be issued fully paid, free from all Encumbrances (save as set out in the Articles); 

 

	 	(b)	 rank pari passu and form one class with the fully paid shares of the same class then in issue, subject
to the Articles; 

  

	 	(c)	 entitle the registered holder to receive any dividend or other distribution announced or declared on or after
the date on which the Warrantholder complies with its applicable obligations in Clause 5.2; and 

  

	 	(d)	 be registered in a register of members kept outside the United Kingdom by or on behalf of the Company.

  

	6.4	 No fractions of a Warrant Share shall be allotted or issued on the exercise of any Subscription Entitlement and
no refund will be made to the Warrantholder exercising such Subscription Entitlement with respect to such fractions. If the exercise of any Subscription Entitlement would require a fraction

  
 8 

	 	
of a Warrant Share to be allotted (including but not limited to where these arise as a result of a Value Cap Warrant Shares Adjustment in accordance with Clause 9), the aggregate number of
Warrant Shares so allotted to a Warrantholder will be rounded down to the nearest whole Warrant Share. 

  

	7.	 CASH REDEMPTION 

 

	7.1	 Where an Exercise Event has occurred or is proposed to occur, the Company may in its absolute discretion elect
in the Exercise Notice relating to that Exercise Event to cancel and redeem some or all of the Subscription Entitlement attaching to the Warrants held by each Warrantholder (a Cash Redemption Election) in consideration for a payment in cash
to each Warrantholder equal to either: 

  

	 	(a)	 where the Closing Price of the Class A Ordinary Shares has equalled or exceeded the Value Cap for any 20
Trading Days within the 30-Trading Day period immediately preceding: 

  

	 	(i)	 in respect of a Mandatory Exercise Event, the date of the Mandatory Exercise Event; or 

 

	 	(ii)	 in respect of a Change of Control Exercise Event, the date that the Change of Control is first announced to the
market by the Company or the person or persons acquiring control in connection with the Change of Control; or 

  

	 	(iii)	 in respect of an Early Redemption Exercise Event or a Final Maturity Exercise Event, the date of the Exercise
Notice, 

 the Value Cap multiplied by the number of Warrants held by the relevant Warrantholder in respect of which the
Company has elected to redeem in cash; or 
  

	 	(b)	 where the Closing Price of the Class A Ordinary Shares has not equalled or exceeded the Value Cap for any
20 Trading Days within the 30-Trading Day period immediately preceding: 

  

	 	(i)	 in respect of a Mandatory Exercise Event, the date of the Mandatory Exercise Event; or 

 

	 	(ii)	 in respect of a Change of Control Exercise Event, the date that the Change of Control is first announced to the
market by the Company or the person or persons acquiring control in connection with the Change of Control; or 

  

	 	(iii)	 in respect of an Early Redemption Exercise Event or a Final Maturity Exercise Event, the date of the Exercise
Notice, 

 the Closing Price on the Trading Day immediately prior to the relevant date referred to in subparagraphs (i),
(ii) or (iii) above (as applicable) multiplied by the number of Warrants held by the relevant Warrantholder in respect of which the Company has elected to redeem in cash (provided that if the relevant Closing Price is greater than the Value
Cap, it shall be deemed to be the Value Cap), 
 (each such payment, a Cash Redemption Payment). 

 

	7.2	 Where a Cash Redemption Election is made, the Subscription Entitlement (or the relevant proportion of the
Subscription Entitlement, as the case may be) of a Warrantholder shall not be treated as cancelled and redeemed unless and until the Cash Redemption Payment has been made in full to the relevant Warrantholder or, if the relevant Warrantholder fails
to notify the Company of its account details in accordance with Clause 5.2, to a ring-fenced bank account to be held for the benefit of the relevant Warrantholder. 

  
 9 

	7.3	 Upon cancellation and redemption of the Subscription Entitlement (or the relevant proportion of the
Subscription Entitlement, as the case may be) in accordance with this Clause 7, all rights and obligations of the Company and the Warrantholders in respect of the Warrants shall immediately terminate and cease to have any force or effect save for
any rights which may have accrued prior to the relevant redemption. 

  

	8.	 ADJUSTMENT OF SUBSCRIPTION ENTITLEMENT 

 

	8.1	 If, while any Subscription Entitlement remains exercisable: 

 

	 	(a)	 there is a subdivision, consolidation, reclassification or change in nominal value (excluding a change to no
par value where the number of shares in issue is otherwise unchanged) of the Class A Ordinary Shares; 

  

	 	(b)	 there is a reduction of capital (of whatever nature, but excluding a cancellation of capital that is lost or
not represented by available assets), or any other reduction in the number of Equity Shares in issue from time to time; 

  

	 	(c)	 there is an issue of Equity Shares by way of dividend or distribution; 

 

	 	(d)	 there is an issue of Equity Shares by way of capitalisation of profits or reserves (including share premium
account and any capital redemption reserve); or 

  

	 	(e)	 there is a consolidation, amalgamation or merger of the Company with or into another entity (other than a
consolidation, amalgamation or merger following which the Company is the surviving entity and which does not result in any reclassification of, or change in, the Class A Ordinary Shares) through a share-for-share exchange or otherwise (including, for the avoidance of doubt, a merger or amalgamation where the Company is not the surviving entity), 

then: 
  

	 	(i)	 the Company shall adjust the Subscription Entitlement and/or the Subscription Price conditional on any such
event occurring, but with effect from the date of the relevant event or, if earlier, the record date for the event (an Adjustment), in each case, so that after such Adjustment, the total number of Warrant Shares for which the outstanding
Subscription Entitlement would then be capable of being exercised carry as nearly as possible (and in any event not less than) the same proportion of the voting rights and the same entitlement (expressed as a proportion of the total entitlement
conferred by all the Equity Shares) to participate in the profits and assets of the Company as if there had been no such event giving rise to the Adjustment and the Company shall procure the update of the Register accordingly; and

  

	 	(ii)	 upon any Adjustment, the Value Cap shall be deemed to be adjusted as follows and construed accordingly (a
Value Cap Adjustment): 

 A = (B divided by C) multiplied by D  

where:  
 A = the
adjusted Value Cap; 
 B = the number of Warrant Shares for which the outstanding Subscription Entitlement would be capable of being
exercised immediately prior to the relevant Adjustment; 

  
 10 

 C = the number of Warrant Shares for which the outstanding Subscription Entitlement
would be capable of being exercised immediately following the relevant Adjustment as determined in accordance with subparagraph (i) above; and  

D = the Value Cap immediately prior to the relevant Adjustment. 

 

	8.2	 The Company shall give the Warrantholders’ Representative written notice of any event described in Clause
8.1, together with details of the relevant Adjustment and Value Cap Adjustment and reasonable detail of any supporting calculations, at the time of, or as soon as reasonably possible after the occurrence of such event. 

 

	9.	 ADJUSTMENT OF WARRANT SHARES 

 

	9.1	 If in an Exercise Notice the Company elects to satisfy a Warrantholder’s Subscription Entitlement in whole
or in part by way of issuing Warrant Share and the Closing Price on the Trading Day immediately prior to the relevant date as follows: 

  

	 	(a)	 in respect of a Mandatory Exercise Event, the date of the Mandatory Exercise Event; or 

 

	 	(b)	 in respect of a Change of Control Exercise Event, the date that the Change of Control is first announced to the
market by the Company or the person or persons acquiring control in connection with the Change of Control; or 

  

	 	(c)	 in respect of an Early Redemption Exercise Event or a Final Maturity Exercise Event, the date of the Exercise
Notice, 

 is equal to or exceeds the Value Cap, the number of Warrant Shares to which a Warrantholder shall be entitled
per Warrant (notwithstanding and subject always to the Company’s right to elect in an Exercise Notice to redeem the Subscription Entitlement by making a Cash Redemption Payment in accordance with Clause 7) shall be adjusted downwards as
follows: 
 A = B divided by C  

where: 
 A = the adjusted
number of Warrant Shares to which a Warrantholder is entitled per Warrant;  
 B = the Value Cap; and  

C = the Closing Price. 
  

	9.2	 Where applicable the Company shall notify the Warrantholders of any Value Cap Warrant Shares Adjustment in the
relevant Exercise Notice and shall include reasonable detail of the calculation of such Value Cap Warrant Shares Adjustment. 

  

	10.	 DETERMINATION BY AUDITORS OR INDEPENDENT FINANCIAL ADVISER 

 

	10.1	 If the Warrantholders’ Representative notifies the Company in writing: 

 

	 	(a)	 within ten Business Days of receipt of a notice given under Clause 8.2 that the Warrantholder Majority
disagrees with any Adjustment and/or any Value Cap Adjustment; or 

  

	 	(b)	 within five Business Days of receipt of an Exercise Notice in which the Company has notified the Warrantholders
of a Value Cap Warrant Shares Adjustment that the Warrantholder Majority disagrees with such Value Cap Warrant Shares Adjustment, the Company shall refer the matter to the Auditors for determination. 

  
 11 

	10.2	 In respect of any disagreement referred to the Auditors for determination pursuant to Clause 10.1:

  

	 	(a)	 the Company and the Warrantholder(s) will each co-operate with the
Auditors in resolving the disagreement as soon as reasonably possible and for that purpose will, subject to any restrictions imposed by applicable law, any regulatory authority or any obligations of confidentiality, provide to them all such
information and documents as they may reasonably require; 

  

	 	(b)	 the Auditors shall have the right to seek such professional assistance and advice as they may require;

  

	 	(c)	 the Auditors’ fees and any professional costs incurred by them shall be borne: 

 

	 	(i)	 where the Auditors’ determination in respect of the relevant matter that is the subject of the
disagreement is more than 5 per cent. less or more than 5 per cent. greater than the original number or calculation proposed by the Company, by the Company; or 

 

	 	(ii)	 in all other cases, (A) 50 per cent. by the Company; and (B) 50 per cent. proportionately among the
Warrantholders that disagreed with the matter (as the Warrantholders’ Representative may determine in its absolute discretion); and 

  

	 	(d)	 the Auditors shall act as experts and not as arbitrators and their decision shall (in the absence of manifest
error) be final and binding on the Company and all Warrantholders. 

  

	10.3	 If the Warrantholders’ Representative notifies the Company in writing within five Business Days of receipt
of an Exercise Notice that the Warrantholder Majority disagrees with the Closing Price specified in such Exercise Notice (where applicable), the Company shall refer the matter to an Independent Financial Adviser for determination, provided that if
the disputed Closing Price was first determined by an Independent Financial Adviser on behalf of the Company prior to issuing the Exercise Notice, the Company shall refer the matter to a second Independent Financial Adviser for determination.

  

	10.4	 In respect of any disagreement referred to an Independent Financial Adviser for determination pursuant to
Clause 10.3: 

  

	 	(a)	 the Company and the Warrantholder(s) will each co-operate with the
Independent Financial Adviser in resolving the disagreement as soon as reasonably possible and for that purpose will, subject to any restrictions imposed by applicable law, any regulatory authority or any obligations of confidentiality, provide to
them all such information and documents as they may reasonably require; 

  

	 	(b)	 the Independent Financial Adviser shall have the right to seek such professional assistance and advice as it
may require; 

  

	 	(c)	 the Independent Financial Adviser’s fees and any professional costs incurred by them shall be borne:

  

	 	(i)	 where the Independent Financial Adviser’s determination in respect of the relevant matter that is the
subject of the disagreement is more than 5 per cent. less or more than 5 per cent. greater than the original number or calculation proposed by the Company, by the Company; or 

  
 12 

	 	(ii)	 in all other cases, (A) 50 per cent. by the Company; and (B) 50 per cent. proportionately among the
Warrantholders that disagreed with the matter (as the Warrantholders’ Representative may determine in its absolute discretion); and 

  

	 	(d)	 the Independent Financial Adviser shall act as an expert and not as an arbitrator and its decision shall (in
the absence of manifest error) be final and binding on the Company and all Warrantholders. 

  

	11.	 UNDERTAKINGS AND INFORMATION 

 

	11.1	 For so long as any Subscription Entitlement remains exercisable, the Company shall: 

 

	 	(a)	 procure that the Board shall at all times have authority pursuant to the Articles and any applicable legal and
regulatory requirements to grant Warrants and to issue Warrant Shares on exercise of any Subscription Entitlement in accordance with the terms of this Instrument and free of any Encumbrances; 

 

	 	(b)	 not permit any of the events described in Clause 8.1(a) to Clause 8.1(e) to the extent that its effect would be
that, following any relevant Adjustment, on the exercise of any Subscription Entitlement the Company would be required to allot Warrant Shares at a discount to nominal value; and 

 

	 	(c)	 subject to applicable law, regulation and the rules of any applicable stock exchange, notify each Warrantholder
of any anticipated Exit, or commencement of proceedings to effect a winding up in the circumstances set out in Clause 12.1, as soon as reasonably practicable after the Board becomes aware of such Exit or winding up (and, in any event, no later than
five Business Days prior to completion of such Exit or passing of the resolution referred to in Clause 12.1(b), as the case may be). 

  

	11.2	 Each Warrantholder (or agent appointed to act on its behalf) shall have the right to attend and speak (but not,
by virtue of its Warrants alone, vote) at all meetings of the holders of the Class A Ordinary Shares at which any business is to be moved which will, or may reasonably be expected to, affect the value of the Warrants or the Warrant Shares or
the rights attaching to any of them under this Instrument. 

  

	12.	 WINDING UP 

  

	12.1	 This Clause 12 applies if: 

 

	 	(a)	 any Subscription Entitlement remains unexercised; and 

 

	 	(b)	 an effective resolution for the winding up of the Company is passed for the summary (solvent) winding up of the
Company under Part 21, Chapter 2 of the Law. 

  

	12.2	 In the circumstances set out in Clause 12.1, each Warrantholder with unexercised Subscription Entitlement
shall, for the purposes of ascertaining its rights in the winding up, be treated as if it had, immediately before the passing of the resolution, fully exercised its outstanding Subscription Entitlement (and, notwithstanding the time periods
specified in Clause 6.1, been issued with Warrant Shares with immediate effect) and shall be entitled to receive out of the assets available in the liquidation pari passu with the holders of the Class A Ordinary Shares (or other Warrant
Shares as may be required following an Adjustment) such sum as it would have received had it been the holder of all such Class A Ordinary Shares (or such other Warrant Shares as may be required following an Adjustment) to which it would have
been entitled by virtue of that exercise after deducting a sum equal to the sum which would have been payable for Warrant Shares, but nothing in this Clause 12 shall require a Warrantholder to make any payment to the Company or any other person.

  
 13 

	13.	 TRANSFER OF WARRANTS 

The provisions of paragraph 2 of Schedule 4 shall govern the transfer of Warrants. 

 

	14.	 MEETINGS OF WARRANTHOLDERS 

All resolutions and consents of the Warrantholders shall be adopted by way of Warrantholder Consent. Nevertheless, if a meeting of the
Warrantholders is to be held, all the provisions of the Articles and any applicable statutory requirements relating to general meetings shall apply to that meeting as if: 
  

	 	(a)	 the Warrants constituted shares in the capital of the Company; and 

 

	 	(b)	 each Warrantholder was a member of the Company, 

provided that the quorum for such a meeting shall be such number of Warrantholders present in person, by proxy or by authorised representative
holding 50% in nominal amount of the Warrant Shares subject to outstanding Warrants on the date of the meeting. 
  

	15.	 WARRANTHOLDERS’ REPRESENTATIVE 

 

	15.1	 The Warrantholders’ Representative shall be entitled to carry out the functions conferred on it by this
agreement. 

  

	15.2	 The Warrantholders’ Representative shall not be liable to any Warrantholder for any act or omission in
connection with the performance by the Warrantholders’ Representative (in that capacity) of its duties, functions and/or role pursuant to this Instrument, except in the case of its fraud or dishonesty. The Warrantholders’ Representative
may act upon any instrument or written communication believed by the Warrantholders’ Representative to be genuine and to be signed and presented by the proper person(s). Each of the Warrantholders hereby undertakes to indemnify and keep
indemnified and hold harmless the Warrantholders’ Representative from all losses, costs, damages, expenses (including professional fees) and any other liabilities that may be incurred by the Warrantholders’ Representative (in that
capacity) as a result of performance of its duties, functions and role as the Warrantholders’ Representative under this agreement provided that the Warrantholders’ Representative shall not be entitled to indemnification for and in respect
of any matter where its actions or inactions are fraudulent or dishonest. 

  

	15.3	 Any consent given in accordance with the provisions of this Instrument by the Warrantholders’
Representative in connection with this Instrument shall bind all the Warrantholders. 

  

	16.	 TAX 

All payments by the Company under this Instrument shall be made free and clear of any Tax Deduction, unless such withholding or deduction is
required by law. In the event of a Tax Deduction being made by the Company in respect of a payment made by it, the Company shall pay such additional amounts as will result in the receipt by the Warrantholders, after any withholding or deduction for
or on account of such taxes, duties, assessments or charges, of such amounts as would have been received by them if no such Tax Deduction had been required. 
  

	17.	 PAYMENTS 

  

	17.1	 Unless otherwise expressly stated (or as otherwise agreed in the case of a given payment), each payment to be
made to the Company and to a Warrantholder under this Instrument or in respect of any Warrant shall be made in US dollars by transfer of the relevant amount into the relevant account on the date (and, if applicable, at or before the time) the
payment is due for value on that date and in immediately available funds.     

  
 14 

	17.2	 The relevant account for a given payment to the Company is: 

 

					
		 	bank:	  	Barclays Bank PLC
		 	sort code:	  	20-36-47
		 	account number:	  	53060166
		 	account name:	  	BHL Fundraising USD
		 	SWIFT:	  	BARCGB22
		 	IBAN:	  	GB34BARC20364753060166

 or such other US dollar account in the name of the Company as shall be: (i) notified to the
Warrantholders’ Representative not less than three Business Days before the date that payment is due for the purpose of that payment; and (ii) approved by the Warrantholders’ Representative following the Company’s compliance with
anti-money laundering requirements to the satisfaction of the Warrantholders. 
  

	17.3	 The relevant account for a given payment to a Warrantholder is the US dollar account specified by the
Warrantholder (or the Warrantholders’ Representative on its behalf), not less than three Business Days before the date that payment is due, by giving notice to the Company in accordance with Clause 21 for the purposes of that payment. In the
absence of any such notice the relevant payment shall be made to a ring-fenced bank account and held for the benefit of the relevant Warrantholder. 

  

	18.	 VARIATION 

  

	18.1	 Subject to Clause 8 and Clause 18.2, no variation or abrogation of the terms of this Instrument or of all or
any of the rights for the time being attached to the Warrants shall be effective (whether or not the Company is being wound up) without Warrantholder Consent. Any such variation or abrogation shall be effected by way of deed poll executed by the
Company and expressed to be supplemental to this Instrument. 

  

	18.2	 Modifications to this Instrument which are of a minor or administrative nature only, and have no impact on the
rights and obligations under this Instrument, may be effected by way of deed poll executed by the Company and expressed to be supplemental to this Instrument. 

 

	18.3	 The Company shall, within five Business Days of making any variation pursuant to this Clause 18, send to each
Warrantholder (or, in the case of joint holders, to the Warrantholder named first in the Register) a copy of the deed poll (or other document) effecting the variation. 

 

	19.	 SEVERANCE 

If any provision or part-provision of this Instrument is or becomes invalid, illegal or unenforceable, it shall be deemed modified to the
minimum extent necessary to make it valid, legal and enforceable. If such modification is not possible, the relevant provision or part-provision shall be deemed deleted. Any modification to or deletion of a provision or part-provision under this
Clause 19 shall not affect the validity and enforceability of the rest of this Instrument. 
  

	20.	 THIRD PARTY RIGHTS 

 

	20.1	 Except as expressly provided in Clause 20.2, a person who is not a party to this Instrument shall not have any
rights under the Contracts (Rights of Third Parties) Act 1999 or otherwise to enforce any term of this Instrument. 

  

	20.2	 The provisions of this Instrument are intended to confer rights and benefits on the Warrantholders and the
Warrantholders’ Representative and such rights and benefits shall be enforceable by each of them to the fullest extent permitted by law. 

  
 15 

	20.3	 The Company undertakes that it will duly observe and perform the obligations on its part contained in this
Instrument and the Warrants shall be issued and held subject to and with the benefit of the provisions of this Instrument. 

  

	21.	 NOTICES 

Any notice to be given to or by any Warrantholder(s) for the purposes of this Instrument shall be given in accordance with the provisions of
paragraph 4 of Schedule 4. 
  

	22.	 GOVERNING LAW AND JURISDICTION 

 

	22.1	 This Instrument and any dispute or claim arising out of or in connection with it or its subject matter or
formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with English law. 

 

	22.2	 Each party irrevocably agrees that the English courts shall have exclusive jurisdiction to settle any dispute
or claim arising out of or in connection with this Instrument or its subject matter or formation (including non-contractual disputes or claims). 

 

	23.	 PROCESS AGENT 

 

	23.1	 Without prejudice to any other mode of service allowed under any relevant law, the Company:

  

	 	(a)	 irrevocably appoints Babylon Partners Limited with registered number 08493276, the registered office of which
is at 1 Knightsbridge Green, London, England, SW1X 7QA as its agent for service of process in relation to any proceedings before the English courts in connection with this Instrument; and 

 

	 	(b)	 agrees that failure by an agent for service of process to notify the Company of the process will not invalidate
the proceedings concerned. 

  

	23.2	 If any person appointed as an agent for service of process is unable for any reason to act as agent for service
of process, the Company shall immediately (and in any event within five days of such event taking place) appoint another agent on terms acceptable to the Warrantholders’ Representative. Failing this, the Warrantholders’ Representative may
appoint another agent for this purpose. 

 THIS DEED has been entered into on the date stated at the beginning of it. 

  
 16 

 SCHEDULE 1 

INITIAL WARRANTHOLDERS 
  

							
	 Name
	  	 Address
	  	 E-mail
Address
	  	Number of Warrants
	AlbaCore Partners II Investment Holdings D Designated Activity Company	  	10 Earlsfort Terrace, Dublin, Dublin, D02 T380, Ireland (copy to: 55 St James’s Street, London, SW1A 1LA)	  	Notices@albacorecapital.com (with a copy to Ipeer@albacorecapital.com and legal@albacorecapital.com)	  	509,675
				
	AlbaCore Partners III Investment Holdings Designated Activity Company	  	10 Earlsfort Terrace, Dublin, Dublin, D02 T380, Ireland (copy to: 55 St James’s Street, London, SW1A 1LA)	  	Notices@albacorecapital.com (with a copy to Ipeer@albacorecapital.com and legal@albacorecapital.com)	  	1,203,887
				
	AlbaCore Strategic Investments LP	  	Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (copy to: 55 St James’s Street, London, SW1A 1LA)	  	Notices@albacorecapital.com (with a copy to Ipeer@albacorecapital.com and legal@albacorecapital.com)	  	43,937

  
 17 

 SCHEDULE 2 

FORM OF WARRANT CERTIFICATE 
 THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE.     

WARRANT CERTIFICATE NO. [__] 

BABYLON HOLDINGS LIMITED  

a public limited company incorporated and registered in Jersey 

registered number: 115471 

registered office: [13 Castle Street, St Helier, Jersey, JE1 1ES] 

(the Company) 
  

			
	 Date of issue:
	  	 [●]

		
	 Warrantholder name:
	  	 [●]

		
	 Registered address:
	  	 [●]

		
	 Principal place of business:
	  	 [●]

 THIS IS TO CERTIFY that the person named above is the registered holder of [●] Warrants, which entitle the
Warrantholder to subscribe for Warrant Shares at the Subscription Price on the terms and subject to the conditions set out in the warrant instrument issued by the Company on [●] 2021 (the Instrument), subject to the Articles. 

This certificate is issued with the benefit of, and subject to, the terms of the Instrument, a copy of which is available on request from the Company. The
Warrants represented by this certificate and the Subscription Entitlement relating to such Warrants are not transferable except in accordance with the Instrument. Terms defined in the Instrument have the same meaning when used in this
certificate.     
  

															
	 EXECUTED as a DEED and DELIVERED by
	 		 	 	)	 	 				  		  	
	 BABYLON HOLDINGS LIMITED
	 		 	 	)	 	 	 	        	 	  		  	
	 acting by a duly authorised director
	 		 	 	)	 	 				  		  	
	 in the presence of:
	 		 	 	)	 	 				  	  
	  	

									
				
	 Witness Signature:
	 	  
	 				  	
				
	 Witness Name:
	 	  
	 				  	
				
	 Witness Address:
	 	  
	 				  	
			
	  
	 				  	
			
	     
	 				  	
				
	 Witness Occupation:
	 	  
	 				  	

  
 18 

 SCHEDULE 3 

FORM OF EXERCISE NOTICE 
  

			
		  	 The Directors
 Babylon Holdings
Limited
 13 Castle Street
 St Helier

Jersey JE1 1ES

 To: 
 Warrantholders’
Representative 
 By e-mail to: [●] 

[DATE] 
 We refer to the warrant instrument dated [●] 2021
(the Instrument) issued by Babylon Holdings Limited. Terms defined in the Instrument have the same meanings when used in this Exercise Notice. 
 We
hereby give notice of [details of Exercise Event], which constitutes a[n] [Mandatory Exercise Event][Early Redemption Exercise Event][Change of Control Exercise Event][Final Maturity Exercise Event] for the purposes of the Instrument.

 For the purposes of clause 5.1 of the Instrument: 
  

	1.	 the Subscription Entitlement [was][shall be] deemed to be automatically and irrevocably exercised on
[date] [at [time]]; 

  

	2.	 the Company will satisfy the aggregate Subscription Entitlement by [issuing an aggregate number of [●]
Warrant Shares [and]][making an aggregate Cash Redemption Payment of [●] [(net of deduction of an aggregate Subscription Price of US$[●] in respect of the number of Warrant Shares to be issued (rounded up to the nearest US$0.01)]];

  

	3.	 the [Warrant Shares [and]][Cash Redemption Payment shall be allocated among the Warrantholders as set out in
the Schedule to this Exercise Notice; 

  

	4.	 the Exercise Completion Date shall be [date]; 

 

	5.	 [the number of Warrant Shares to be issued to the Warrantholders on the Exercise Completion Date as set out in
paragraph 2 and the Schedule to this Exercise Notice has been subject to a Value Cap Warrant Shares Adjustment calculated as follows: [reasonable detail to be included];] 

 

	6.	 [the Cash Redemption Payment to be made to the Warrantholders on the Exercise Completion Date as set out in
paragraph 2 and the Schedule to this Exercise Notice has been calculated as follows: [reasonable detail to be included]; [and] 

  

	7.	 [the [Closing Price] for the purposes of the calculations referred to in paragraph[s] [●] above
[has][have] been determined as follows [reasonable detail to be included]. 

 We hereby request that each Warrantholder
complies with its obligations pursuant to Clause 5.2 of the Instrument within the applicable time period specified therein. 

  
 19 

							
	Signed by [NAME OF DIRECTOR] for and on behalf of Babylon Holdings Limited 	 	    	  	  
 [SIGNATURE OF
DIRECTOR]
	  	
		 		  	Director	  	

 SCHEDULE TO EXERCISE NOTICE 

[Details of allocation of Warrant Shares and/or Cash Redemption Payment among Warrantholders to be included] 

  
 20 

 SCHEDULE 4 

THE CONDITIONS 
  

	1.	 THE REGISTER AND CERTIFICATES 

 

	1.1	 The Register shall be kept and maintained at the Registered Office or at such other place (at all times outside
the United Kingdom) as the Company may from time to time determine and notify to the Warrantholders and there shall promptly be entered in the Register: 

  

	 	(a)	 the names and addresses of the Warrantholders, supplied in accordance with paragraph 4 of this Schedule 4;

  

	 	(b)	 the number of Warrants held by each Warrantholder; 

 

	 	(c)	 the date on which each person was registered as a Warrantholder, in respect of each tranche of Warrants held by
it; 

  

	 	(d)	 the date on which the Subscription Entitlement was exercised and the number of Warrants for which such
Subscription Entitlement was exercised; 

  

	 	(e)	 the date on which any person ceased to be a Warrantholder; 

 

	 	(f)	 updates arising out of Adjustments in accordance with Clause 8.1; and 

 

	 	(g)	 all transfers of the Warrants. 

 

	1.2	 The Company shall promptly amend the Register after receiving notice of a change in a Warrantholder’s
details for service pursuant to paragraph 4.4 of this Schedule 4. 

  

	1.3	 The Warrantholders or any of them, or any person authorised by a Warrantholder, shall be at liberty at all
reasonable times during office hours to inspect the Register and to take copies of or extracts from it or any part of it. 

  

	1.4	 The Company shall be entitled to treat each person named in the Register as a Warrantholder as the absolute
owner of a Warrant and, accordingly, shall not, except as ordered by a court of competent jurisdiction or as required by law, be bound to recognise any equitable or other claim to or interest in a Warrant on the part of any other person, whether or
not it shall have express or other notice of such a claim. 

  

	1.5	 Every Warrantholder shall be recognised by the Company as entitled to its Warrants free from any equity, set-off or cross-claim against the original or an intermediate holder of such Warrants. 

  

	1.6	 Each Warrantholder shall be issued with a Certificate (together with a copy of this Instrument and, at the
Warrantholder’s request, a copy of any other document referred to in this Instrument) promptly and, in any event, within ten Business Days, following: 

  

	 	(a)	 the date on which it is registered as a Warrantholder; and 

 

	 	(b)	 any Adjustment (except where such Adjustment is referred to the Auditors for determination in accordance with
Clause 10, in which case, following completion of the Auditors’ determination). 

  

	1.7	 If a Certificate is mutilated, defaced, lost, stolen or destroyed, it will be replaced by the Company upon
payment by the claimant of such reasonable costs as may be incurred in connection with such replacement and on such terms as to evidence and indemnity as the Company may reasonably require. Mutilated or defaced Certificates must be surrendered
before replacements will be issued. 

  
 21 

	2.	 TRANSFER OF WARRANTS 

 

	2.1	 No Warrantholder shall assign, transfer, mortgage, charge, declare a trust over, or deal in any other manner
with its Warrants or any of its rights in respect of the Warrants (each such transaction, a Transfer) without the express prior written approval of the Board (such approval to be given in the absolute discretion of the Board), other than:

  

	 	(a)	 to a Permitted Transferee of the Warrantholder; or 

 

	 	(b)	 where a Transfer of Notes is permitted pursuant to the terms of the Notes Deed Poll, 

in each case, provided that a Transfer of Notes is made simultaneously to the same person and the number of Warrants the subject of the
Transfer is equal to the Equivalent Proportion. 
  

	2.2	 Subject to paragraph 2.1, Warrants may be transferred by means of (and only by means of) an instrument of
transfer in any usual form or any other form approved by the Board acting reasonably. 

  

	2.3	 An instrument of transfer shall be made under hand and executed by or on behalf of the transferor but need not
be signed by the transferee. The transferor shall be deemed to remain the holder of the Warrants until the name of the transferee is entered in the Register for the Warrants being transferred. 

 

	2.4	 The Board may refuse to register a transfer unless such instrument is deposited at the Registered Office
together with any Certificate(s) issued by the Company in respect of such Warrants (or deed of indemnity in favour of the Company on such terms as the Company may reasonably require in the case of any lost, damaged or destroyed Certificates) and
such other evidence as the Board may reasonably require to show the right of the transferor to make the transfer. 

  

	2.5	 The registration of a transfer shall be conclusive evidence of approval by the Board of the transfer.

  

	2.6	 No fee shall be charged for the registration of a transfer of a Warrant, or for the registration of any other
documents which, in the opinion of the Board, require registration. 

  

	2.7	 Any transfer of a Warrant purported to be made otherwise than in accordance with this paragraph 2 shall be void
and have no effect. 

  

	3.	 CONFIDENTIALITY 

 

	3.1	 A Warrantholder shall not at any time disclose to any person the existence of or contents of this Instrument,
or any confidential information concerning the business, affairs, customers, clients or suppliers of the Group, except as permitted by paragraph 3.2. 

  

	3.2	 A Warrantholder may disclose information, where such disclosure would otherwise be prohibited under paragraph
3.1 if and to the extent: 

  

	 	(a)	 the information is or becomes publicly available (other than by breach of this Instrument by the
Warrantholder); 

  

	 	(b)	 the Company has given prior approval to the disclosure or use; 

 

	 	(c)	 the information is information about the Group which the board of directors of the Company has confirmed in
writing to a Warrantholder is not confidential; 

  
 22 

	 	(d)	 the information is independently developed by a Warrantholder after the date of this Instrument;

  

	 	(e)	 the disclosure or use is required by legal or regulatory requirements, any governmental or regulatory body or
any stock exchange on which the shares of a Warrantholder or any of its Associated Companies is listed (including where this is required as part of any actual or potential offering, placing and/or sale of securities of that Warrantholder or any of
its Associated Companies) or requested by any court of competent jurisdiction or any relevant governmental, judicial, supervisory, regulatory or self-regulatory body; 

 

	 	(f)	 the disclosure or use is required for the purpose of any judicial proceedings arising out of this Instrument or
any documents to be entered pursuant to it; 

  

	 	(g)	 the disclosure of information is to any tax authority to the extent such disclosure is reasonably required for
the purposes of the tax affairs of a Warrantholder or any of its Associated Companies; 

  

	 	(h)	 provided that in the event that any demand or request for disclosure of such information is made pursuant to
paragraph 3.2(e) to (g) above, such Warrantholder shall (to the extent reasonably practicable to do so and, further, subject to such notification not being in breach of any applicable confidentiality obligations) promptly notify the Company of
the existence of such request or demand and shall provide the Company with a reasonable opportunity to seek an appropriate protective order or other remedy, which both the Warrantholders and Company will cooperate in seeking to obtain. In the event
that such appropriate protective order or other remedy is not obtained, the Warrantholder shall furnish, or cause to be furnished, only that portion of the confidential information that is legally required to be disclosed; 

 

	 	(i)	 the disclosure by a Warrantholder or its Associated Companies is to any of its Associated Companies, Related
Funds and any of its or their officers, directors, employees, professional advisers, auditors, partners and representatives and is in respect of such information as such Warrantholder or such Associated Companies shall consider reasonably
appropriate, provided that any person to whom the information is to be given pursuant to this paragraph 3.2(i) is informed in writing of its confidential nature and that some or all of such information may be price-sensitive information provided
further that that there shall be no such requirement to so inform if the recipient is subject to professional obligations to maintain the confidentiality of the information or is otherwise bound by requirements of confidentiality in relation to such
information; 

  

	 	(j)	 the disclosure of information is on a confidential basis to any bona fide proposed transferee of
Warrants (including any Permitted Transferee, third party, professional advisers, auditors, insurers or financiers of such party) wishing to acquire Warrants from a Warrantholder in accordance with the terms of this Instrument to the extent that any
such persons need to know the information for the purposes of considering, evaluating, advising on or furthering the potential purchase, or to service providers and professional advisors who in their ordinary course of carrying out their services
for such Warrantholder or its Associated Companies may come into contact with confidential information and who are bound by an obligation of confidentiality to such Warrantholder or is otherwise subject to professional obligations to maintain the
confidentiality of the information; and 

  

	 	(k)	 the disclosure is to: 

 

	 	(i)	 another Warrantholder; and 

 

	 	(ii)	 the Warrantholders’ Representative. 

 

  
 23 

	3.3	 No Warrantholder shall use any confidential information relating to the Group for any purpose other than to
perform its obligations, or to exercise its rights, under this Instrument. 

  

	4.	 NOTICES 

  

	4.1	 For the purposes of this paragraph 4, but subject to paragraph 4.7, notice includes any other communication.

  

	4.2	 Unless otherwise specified in this Instrument, a notice given to a party under or in connection with this
Instrument: 

  

	 	(a)	 shall be in writing and in English; 

 

	 	(b)	 shall be sent by e-mail (unless a delivery failure message is received
by the sender, in which case it may be sent to the registered address of the recipient by another method referred to in paragraph 4.5(b)): 

  

	 	(i)	 in the case of the Company, to legal-corporate@babylonhealth.com (marked for the attention of the
General Counsel); 

  

	 	(ii)	 in the case of the Initial Warrantholders, to the Warrantholders’ Representative at
Ipeer@albacorecapital.com and legal@albacorecapital.com (marked for the attention of Itay Peer and Joe Ohlson), or such other e-mail address or person as that person may notify to the Company in accordance
with the provisions of this paragraph 4; and 

  

	 	(iii)	 in the case of any Warrantholder (other than the Initial Warrantholders) to such
e-mail address or person as that Warrantholder shall notify to the Company in accordance with the provisions of this paragraph; and 

 

	 	(c)	 unless proved otherwise, is deemed received as set out in paragraph 4.5. 

 

	4.3	 Each Warrantholder (other than an Initial Warrantholder) shall register with the Company an e-mail address to which notices can be sent and, if such Warrantholder fails to do so, notice may be given to that Warrantholder by sending the same by any of the methods referred to in paragraph 4.2 to the last
known e-mail address of such Warrantholder or, if none, by sending such notice to the Warrantholders’ Representative. 

 

	4.4	 A Warrantholder may change its details for service of notices by giving notice to the Company following any
change. Any change notified under this paragraph 4.4 shall take effect at 9am (London time) on the later of: 

  

	 	(a)	 the date (if any) specified in the notice as the effective date for the change; or 

 

	 	(b)	 five Business Days after deemed receipt of the notice. 

 

	4.5	 Delivery or receipt (as the case may be) of a notice is deemed to have taken place (if all other requirements
in this paragraph 4 have been satisfied): 

  

	 	(a)	 if sent by e-mail, at the time of transmission (provided that no
delivery failure message is received by the sender); or 

  

	 	(b)	 where a delivery failure message is received by the sender: 

 

	 	(i)	 if delivered by hand, on signature of a delivery receipt or at the time the notice is left at the address;

  
 24 

	 	(ii)	 if sent by pre-paid first class post, recorded delivery or special
delivery to an address in the United Kingdom, at 9am on the second Business Day after posting; or 

  

	 	(iii)	 if sent by reputable international overnight courier to an address outside the country from which it is sent,
on signature of a delivery receipt or at the time the notice is left at the address. 

 If deemed receipt under the
previous sub-paragraphs of this paragraph 4.5 would occur outside business hours (meaning 9am to 5.30pm Monday to Friday on a day that is not a public holiday in the place of deemed receipt), at 9am on the day
when business next starts in the place of deemed receipt. For the purposes of this paragraph 4.5, all references to time are to local time in the place of deemed receipt. 
  

	4.6	 To prove service, it is sufficient to prove that: 

 

	 	(a)	 if delivered by hand or by reputable international overnight courier, the notice was delivered to the correct
address; 

  

	 	(b)	 if sent by e-mail, a transmission report was received confirming that
the notice was successfully transmitted to the correct e-mail address; or 

  

	 	(c)	 if sent by post, the envelope containing the notice was properly addressed, paid for and posted.

  

	4.7	 This paragraph 4 does not apply to the service of any proceedings or other documents in any legal action or,
where applicable, any arbitration or other method of dispute resolution. 

  

	4.8	 All notices with respect to Warrants registered in the names of joint holders shall be given to whichever of
such persons is named first in the Register and any notice so given shall be sufficient notice to all the joint registered holders of such Warrants. 

  

	4.9	 Any person who, whether by operation of law, transfer or other means whatsoever, becomes entitled to any
Warrant, shall be bound by every notice properly given to the person from whom it derives title to such Warrant. 

  

	4.10	 When a given number of days’ notice must be given, the day of service shall be included but the day on
which such notice shall expire shall not be included in calculating the number of days. The signature to any notice to be given by the Company may be written or printed. 

  
 25 

 SIGNATORIES 

EXECUTED as a DEED by 

BABYLON HOLDINGS LIMITED 
  

			
	By:	 	
	
	
	Name:	 	Ali Parsadoust
	Title:	 	Director
		
	By:	 	
	
	
	Name:	 	Mairi Johnson
	Title:	 	Director

  
 26

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]